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ABSTRACT 
The objectives of the first experiment were to ascertain if there were any 
differences between two mouse areola and adipose tissue cell lines.  These cell 
lines differed only in the presence or absence of the hypoxanthine phosphoribosyl 
transferase (HPRT) gene.  It was found that the cell lines were similar for all 
parameters. 
The objectives of the second experiment were to determine if the HPRT 
gene had an effect on the development of preimplantation mouse embryo.  To test 
this transgenic mouse lines were created.  The embryo sex and genotype ratio, the 
embryo diameter, and the embryo developmental patterns, using a Collin-Ryan 
Embryo Development (C-RED) score, were determined.  The sex and genotype 
ratios differed from the expected 1:1.  The experiment concluded that HPRT is 
effecting embryo development and sex ratios 
The objectives of the third experiment were to determine if there is an effect 
of sex and HPRT on the cell number of mouse blastocysts.  It was found that there 
was not an effect of sex, but that HPRT independent of sex was effecting the cell 
number of mouse blastocysts. 
The objectives of the fourth experiments were to determine if the HPRT 
gene in co-culture would have an effect on the development and cell number of 
mouse blastocysts.  The blastocysts co-cultured with cells containing the HPRT 
gene had significantly greater number of blastomeres.  This experiment concluded 
that HPRT in co-culture can alter the cell number of mouse blastomeres. 
 ix
The objective of the fifth experiment was to determine if the same results 
that were seen with the HPRT gene in co-culture on mouse embryos could be found 
with bovine embryos.  There was significantly more blastocyst from co-culture 
with the cells containing the HPRT gene.  There was not a difference in cell 
number of the bovine blastocyst.  
The sixth experiment determined the effect of HPRT inhibitors and an 
inducer on bovine embryo development and sex ratios.  It was found that the 
embryos developed with the inducer in the medium did not have altered sex ratios. 
The results of these experiments demonstrate that HPRT is effecting 
mammalian embryo development.    
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INTRODUCTION 
 
 Male embryos, even at the preimplantation stage, have been shown to grow 
faster than female embryos.  This phenomenon has been observed in several 
species.   While a few research groups have moved beyond the simple reporting of 
this fact and conjectured at the causes, none have provided direct experimental 
evidence implicating a specific gene.   
The following series of experiments are designed to ascertain the effect of 
the X-linked gene, hypoxanthine phosphoribosyl transferase (HPRT), on embryo 
development in the mouse.  The intention is that the identification of a gene 
effecting the growth and sex ratio of mouse embryos will be exploited to alter the 
preimplantation development of an economically valuable species, such as the cow. 
 The first experiment is intended to compare and characterize the growth 
rates, size and cell integrity of two continuous mouse cell lines.  These cell lines 
differ only in the presence (HPRT-positive) or absence (HPRT-negative) of the 
hypoxanthine phosphoribosyl transferase gene.  Data will be collected and analyzed 
from 10 passages of the cell lines.  The differences in cell number from passage to 
passage (both within and between cell lines), the cell diameter and membrane 
integrity will be recorded. 
 Transgenic mouse lines will be created for the second and third 
experiments.  The embryos from these transgenic lines will be used to compare the 
effect of overexpression of HPRT in embryos on the embryonic sex ratio.  This will 
serve as an indication of the role of HPRT in the sexual dimorphism of mammalian 
preimplantation embryos.  Information will also be collected on the growth rates, 
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size and cell number of the embryos.  This will be in addition to the data 
establishing the overexpression of the HPRT gene in the transgenic mouse 
embryos. 
 The fourth experiment will ascertain if any previous effect of HPRT on the 
growth and cell number of mouse embryos can be replicated with an extra-
embryonic source of increased HPRT.  To accomplish this mouse embryos will be 
co-cultured with cells containing and missing the HPRT gene.  The growth of the 
embryos will be monitored, and the resulting embryonic cell number will be 
determined.  The fifth experiment will be identical to the fourth but bovine 
embryos will be substituted for the mouse embryos.   This will be done to 
determine if similar results can be obtained with this economically valuable 
species. 
 The sixth experiment will determine if the pharmacological alteration of the 
activity of embryonic HPRT gene will alter the embryo size or sex ratio.  This will 
be accomplished by exposing bovine embryos, both with and without increased 
concentrations of glucose, to several inhibitors or inducers of HPRT.  The resulting 
sex ratio of the treatment groups and mean diameter of the embryos will be 
determined. 
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REVIEW OF LITERATURE 
 
Embryo Sexual Dimorphism 
Review of Current Knowledge 
 In recent years it has become accepted fact that mammalian male embryos 
develop faster to the blastocyst stage than female embryos (Avery et al., 1989; 
Kochhar et al., 2001). 
 Peippo and Bredbacka (1995), in a complicated experiment with BCf1 mice, 
detected a difference in the sex ratio of embryos collected on day 3 of pregnancy 
when the embryos were partitioned into three groups based on morphology (less 
than 8-cell, 8-cell and compacted morulae).  The compacted morula group, 
surprisingly, had a significant greater percentage of female embryos. While there 
were even numbers of males and females in the 8-cell group; the less than 8-cell 
group had fewer female than male embryos, although the disparity was not 
significant.  To add to the ambiguity of the study, the experimenters proceeded to 
follow the development of the embryos for another day in vitro.  After this 
additional day the number of cells in the embryo was determined and the increase 
in the cells reported since the previous day.  The report concludes that the male 
embryos had a significantly greater increase in the number of cells from the 
previous day.  So to summarize, this study reported that male embryos had few 
cells on day 3 of pregnancy than female embryos, yet the male embryos were 
growing faster (as determined by the increase in cell number), so by day-4, male 
embryos were significantly more advanced than female embryos.  While the 
conclusions of this study, that male embryos are growing faster, are interesting, the 
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effect of culture media on the growth of the embryos was overlooked.  The fact that 
culture media may select for faster male embryo growth is not mentioned.  This 
study also demonstrates an important point.  When working with sex differences 
and development it is necessary to categorize or select embryos based on a 
parameter of development, since a group or cohort of embryos should in the whole 
represent a 1:1 ratio.  Only by finding the fast or slow developing embryos will the 
ratio be skewed.  This is particularly important when working with in vivo 
embryos, since the culture medium should tend to select for the embryos 
developing faster among IVF-derived embryos. 
 Valdivia et al. (1993) evaluated the sex differences of mouse embryos and 
determined that among IVF-derived C57BL/6N mouse embryos a significant 
difference in development between male and female embryos at the blastocyst 
stage is detectable.  This was determined by classifying the embryos based on 
blastocoel formation at 72 to 80 hours, with those embryos having cavitated 
(formed a blastocoel) at 72 hours classified as fast developing, those cavitating at 
80 hours as slow developing and all others as intermediate.  As stated above, the 
fast developing embryos had a significantly greater number of male embryos and 
the opposite is noted with the slow developing embryos, with the intermediates 
having an equal number of male and female embryos. 
 To add to the disparity of development between male and female mouse 
embryos, a significant difference in the number of somites of day-9 mouse embryos 
at neurulation was reported by Seller and Perkins-Cole (1987).  Furthermore, 
Tsunoda et al. (1985), using live births as an outcome and sex determination 
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method, determined that male embryos developed faster after grouping the embryos 
based on the rate of cleavage. 
 Tarin et al. (1995), in a study with human IVF-derived embryos, a 
significant shift in the sex ratio to 90% males were reported in the fast growing 
group, with an accompanying 88% females in the slowest growing group.  This 
extensive report also mentions that the cleavage rate (one parameter of embryo 
development) does not alone effect the sex ratio but that maternal age is a 
contributing factor.  This paper of course brings to light the fact that in vitro 
fertilization programs may be inadvertently selecting for sex. 
 Avery et al. (1991) grouping bovine embryos based on the day of recovery 
from cows and the blastocoel size, detected a significant alteration in the sex ratio.  
A significant greater number of male embryos were recovered on day 7 of the 
estrous cycle, and those males had larger blastocoels based on the embryo grouping 
parameters used than the female embryos recovered.  Conversely, on day 8 of the 
estrous cycle a greater number of female embryos were recovered and, although it 
is not significant, the female embryos had larger blastocoels.  This study has to be 
questioned since the sex determination technique (karyotyping) only produced 
results for one-half of the embryos.  Still, if it is assumed that the sex of the embryo 
does not have an effect on the success of the karyotyping procedure, the results 
suggest some interesting conclusions. 
 Avery et al. (1992) using similar methods with bovine IVF-derived embryos 
detected similar results.  In this experiment, the embryos were grouped based on 
the appearance and relative size of the blastocoel on day 7, day 8 and day 10 after 
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in vitro fertilization.  As in the previous report with in vivo-produced bovine 
embryos, the embryos with larger blastocoels on day 7 were most likely male and 
on day 10 were most likely female. The overall sex ratio was exactly 1:1, adding 
credence to this study.  Unlike the earlier work (Avery et al., 1989), this study was 
not hampered by unsexed embryos because the more reliable polymerase chain 
reaction method was used to determine the sex. 
 Carvalho et al. (1996) detected similar results with frozen thawed day-7 
bovine IVF-derived embryos.  This study graded the embryos based on blastocoel 
size on day 7 post-insemination, and as with the previous studies, and detected a 
significantly greater number of male embryos in the groups with larger blastocoels.  
However, this report did not address a critical issue of the effect of sex and 
development on cryopreservation.  It is easy to imagine that male embryos having 
larger blastocoels, and perhaps a greater number of cells, could respond differently 
to the sucrose solutions used in cryopreservation procedures. 
 The work of Grisart et al. (1995) refuted these previous results on blastocoel 
size.  This study grouped bovine IVF-derived embryos based on the blastocoel size 
and the day of blastocoel appearance.  While there was an alteration in favor of 
male embryos in all groups none of the values were statistically different, leading 
the researchers to conclude that deviation of the sex ratios does not occur in their 
culture system. 
 Using records from Danish Multiple Ovulation and Embryo Transfer 
(MOET) program, Callesen et al. (1996) retrospectively graded embryos recovered 
from superovulated dairy cows, and using live births resulting from embryo 
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transfer as the sex determination method, did not find an alteration of the sex ratio.  
The authors were quick to point out the significant differences between in vitro 
fertilization and embryo transfer.  These include: 1) that the oocytes from in vitro 
maturation are considered to constitute a more heterogeneous pool than those 
resulting from in vivo maturation; 2) oocytes from IVF programs are selected at 
several points and are excluded from further development; 3) the insemination 
period during in vitro fertilization is precisely defined; 4) in vitro culture conditions 
are very different from the in vivo situation, and more importantly often differ 
significantly from laboratory to laboratory (Betteridge and Rieger, 1993). 
 Thibier and Nibart (1992) compared the sex determination results from both 
the polymerase chain reaction and live births, and found a significance difference 
was not detectable with either sex determination method.  However, unlike many of 
the previously mentioned studies, the embryos were not placed into groups based 
on development, and as has been pointed out the overall sex ratio did not differ 
significantly in these studies; only when developmental stage was considered was a 
deviation in the sex ratio detected. 
 Briefly, it should be mentioned that there is some evidence that many other 
factors may effect the sex of embryos.  These include the length of the uterus and 
ovary (left versus right) from which the oocyte originates (Chen and Dziuk, 1993; 
Clark et al., 1994).  These studies should not be overemphasized since they are of 
an anecdotal nature. 
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Possible Causes 
Even though these studies suffice to reveal the phenomenon of sexual 
dimorphism of preimplantation embryos to date there has not been a serious body 
of work investigating the underlying causes of sexual dimorphism.  The majority of 
statements concerning the mechanism of sexual dimorphism have been primarily 
conjecture. 
It was originally assumed that the presence of a Y-chromosome was 
responsible for the sex differences of mammalian preimplantation embryos (Avery 
et al. 1989; Burgoyne et al. 1993; Zwingman et al. 1993).  However, closer 
investigation of the cellular physiology of mammalian embryos soon revealed that 
the activity of two X-chromosomes prior to X-chromosome inactivation was the 
most likely cause of sexual dimorphism (Peippo and Bredbacka, 1995). 
This has lead to the speculation of which genes may be involved in the 
sexual dimorphism of embryos, and since the majority of the research to date 
concerning gene activity and embryos has focused on cellular metabolism Peippo 
and Bredbacka (1995) focused on the metabolism genes that are linked to the X-
chromosome.  The most noticeable of these are glucose-6-phosphate 
dehydrogenase (G6PD), phosphoglycerate kinase (PGK) and hypoxanthine 
phosphoribosyl transferase (HPRT, also known as hypoxanthine-guanine 
phosphoribosyl transferase HGPRT).  Phosphoglycerate kinase, while it 
metabolizes an important reaction of glycolysis is not necessarily the most likely 
candidate since glycolytic metabolism does not appear to be very active in 
preimplantation embryos (Brackett, 1981).  Glucose-6-phosphate dehydrogenase 
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does present an enticing picture since it is the rate controlling enzyme of a very 
active pathway in preimplantation embryos, the pentose phosphate pathway, and 
there has been a report closely linking glucose-6-phosphate dehydrogenase activity 
to the sex of the embryo (Tiffin et al. 1991).  However, there is not a clear 
mechanism proposed by which glucose-6-phosphate dehydrogenase can effect the 
development of an embryo, even though the pentose phosphate pathway effects 
many cellular functions and more interestingly alters the reactive oxygen species 
(ROS) content of cells.  This last fact has lead Peippo and Bredbacka (1995) to 
speculate that glucose-6-phosphate dehydrogenase and hypoxanthine 
phosphoribosyl transferase (another enzyme that can effect the reactive oxygen 
species content of cells) are the enzymes responsible for the sexual dimorphism of 
embryos by altering the embryo growth in response to altered reactive oxygen 
species concentration.  While there are reasons to exclude glucose-6-phosphate 
dehydrogenase from consideration (Epstein et al., 1978; Kratzer and Gartler, 1978), 
the mechanism by which hypoxanthine phosphoribosyl transferase is altering 
embryo growth is not related to the reactive oxygen species concentrations as 
proposed in Peippo and Bredback (1995), and will be addressed in this dissertation. 
Embryo Development and Metabolism 
Reactive Oxygen Species and Metabolism 
The role of reactive oxygen species should not be disregarded as the cause 
of mammalian embryo sexual dimorphism.  Reactive oxygen species are oxygen 
free radical products of metabolism and the resulting detoxification products (the 
most notable is hydrogen peroxide, H2O2) (Voet and Voet, 1990).  If these species 
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are not acted on quickly by the detoxifying enzymes, namely superoxide dismutase, 
cellular damage may occur (Tatemoto et al., 2000).  This damage is most often seen 
in the plasma membranes and nucleic acids (Aitken et al., 1998).  There is some 
evidence that reactive oxygen species in certain concentrations can increase 
metabolism and have growth stimulating effects (Sohal and Allen, 1990; Reiger, 
1992).  So it is easy to see how an enzyme that produces reactive oxygen species as 
by products can alter developmental rates.  This lead Peippo and Bredbacka (1995) 
to implicate glucose-6-phosphate dehydrogenase and hypoxanthine phosphoribosyl 
transferase in the sexual dimorphism of embryos.  Still, a more introspective review 
of the metabolism of hypoxanthine phosphoribosyl transferase and glucose-6-
phosphate dehydrogenase is needed before conclusions concerning their effects on 
development can be drawn. 
The main parts of embryo metabolism concerning glycolysis, the pentose 
phosphate pathway and purine salvage, are outlined in Figure 1.   During much of 
preimplantation development glycolysis is not active due to the inhibition of 
phosphofructose kinase (Pike, 1981).  It is not clear when glycolysis becomes 
active in preimplantation embryos, but this is most likely species specific and does 
not occur until several cell cycles has passed (Boone et al., 1978).  This of course 
can lead to glucose inhibiting metabolism (possibly by a Crabtree effect; Crabtree, 
1925) and even glucose becoming toxic to embryo development (Davis and Day, 
1978; Gardner and Lane, 1993; Menezo and Khatchadourian, 1990). 
The pentose phosphate pathway, which is controlled by glucose-6-
phosphate dehydrogenase is, however, quite active even though its activity may not 
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Figure 1. Embryo metabolism.  Adenine phosphoribosyl transferase (APRT), 
hypoxanthine phosphoribosyl transferase (HPRT), inosine monophosphate (IMP), 
guanine monophosphate (GMP), adenosine diphosphate (ADP) and adenosine 
triphosphate (ATP). (Voet and Voet, 1990). 
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be related to the number of X-chromosomes in the embryo (Epstein et al., 1978; 
Kratzer and Gartler, 1978).  This pathway has two important effects: 1) it produces 
NADPH, which can effectively lower the reactive oxygen species concentration 
and 2) one of its end products is phosphoribosyl pyrophosphate.  Phosphoribosyl 
pyrophosphate is a precursor of nucleotide biosynthesis and more importantly of 
purine salvage.  The activity of hypoxanthine phosphoribosyl transferase will be 
addressed in detail further on, but two aspects of the metabolism around 
hypoxanthine phosphoribosyl transferase have to be mentioned.  First, increased 
hypoxanthine metabolism will decrease the amount of the reactive oxygen species 
(hydrogen peroxide) produced from the xanthine oxidase pathway (Figure 2). 
Second, if de novo purine synthesis is not considered, the available 
phosphoribosyl pyrophosphate will be tied up in either adenosine or guanosine 
depending on the relative activities of adenine phosphoribosyl transferase and 
hypoxanthine phosphoribosyl transferase.  There is some evidence that embryos, 
like neural cells, rely solely on the salvage enzymes adenine phosphoribosyl 
transferase and hypoxanthine phosphoribosyl transferase for purine synthesis 
(Wyngaarden, 1959).  This is not surprising considering the amount of 
hypoxanthine produced from the degradation of the maternal derived mRNA 
during genomic activation (Clegg and Piko, 1983).  Even though the high energy 
phosphates of ATP and GTP are freely transferable thereby, equalizing the free 
energy of charge of a cell, the relative activity of hypoxanthine phosphoribosyl 
transferase can effect the metabolism of the cell by alter the amount of AMP, 
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Figure 2. Hypoxanthine metabolism.  Phosphoribosyl pyrophosphate (PRPP; 
Jiralespong et al., 1996). 
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versus GMP, that is available for phosphorylation to ATP for use by ATP specific 
enzymes (such as the Na+/K+ ATPase). 
Blastocoel Formation 
 As noted previous, the majority of experiments reporting a deviation in 
embryo development due to sex, have grouped the embryos based on the time of 
blastocoel formation and/or blastocoel size.  With this in mind, for the purposes of 
this dissertation (to ascertain if hypoxanthine phosphoribosyl transferase has an 
effect on embryo development and if that enzyme can be manipulated to alter 
development) it is necessary to establish a model for blastocoel formation and 
maintaince. 
 Embryo cavitation (the formation of the blastocoel) has fascinated scientist 
for almost a century.  Melissinos (1907) purposed the first model of cavitation 
based on microscopic observations.  He observed refractile cytoplasmic droplets 
accumulating on the basolateral membrane of the outer blastomere of 16-cell 
mouse embryos.  The fluid then coalesced to form the blastocoel.  This model held 
favor for some time.  However, the work by Calarco and Brown (1969), Flynn and 
Hillman (1978) and Wiley and Eglitis (1980) revealed a problem.  Namely, the 
droplets did not have the same components as blastocoel fluid. 
 The second model proposed ~30 years ago is closer to the currently 
accepted model (Ducibella and Anderson, 1975).  This model states that at the      
8-cell stage the outer blastomeres form tight junctions with the other neighboring 
blastomeres.  Then a movement of ions occurs from the extra-embryonic space 
through the outer blastomeres to the nascent blastocoel with an accompanied flow 
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of water that causes blastocoel expansion.  This model was refuted by Wiley and 
Eglitis (1981), when they pointed out that the embryo could not take up extra-
embryonic fluid with out increasing in volume, and an incidental observations by 
McLaren and Smith (1977) which demonstrated that the embryo was not as 
impermeable as required for the model to work. 
 This leads to the metabolic cavitation model currently held to be correct.  
This model was originally purposed by Wiley (1984).  It states that the droplets 
seen by Melissons (1907) are actually lipids that undergo beta-oxidation to produce 
high energy compounds.  The high energy compounds are then used in the 
phosphorylation of AMP to ATP and the resulting ATP is used to drive Na+/K+ 
ATPases, which are located in the basolateral membrane of the outer blastomeres.  
The Na+/K+ ATPases then increase the amount of Na+ in the blastocoel, which 
through osmotic pressure drives water into the blastocoel, causing it to expand.  
Only the outer blastomeres have tight junctions to maintain the integrity of the fluid 
filled blastocoel (Figure 3). 
Genomic Activation and X-chromosome Inactivation 
 
Genomic Activation 
 From the time of fertilization and for at least the first two cell cycles the 
embryo is under the control of maternally derived transcripts.  At this time the 
control of the embryo switches to the embryonic genome.  This change in control is 
known as genomic activation (Bachvarova and Deleon, 1980).  The timing of 
genomic activation is species dependent, but believed to occur in all species prior 
to compaction at the morula stage (Teleford et al., 1990). 
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Figure 3. Metabolic cavitation model.  Adenosine diphosphate (ADP), adenosine 
triphosphate (ATP), nicotinamide adenine dinucleotide reduced (NADH), 
nicotinamide adenine dinucleotide oxidized (NAD+) (Wiley, 1984). 
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 For the purposes of this report it is interesting to take into consideration the 
events of genomic activation and how the embryo deals with this change in 
metabolism.  During the growth phase of oogenesis RNA synthesis is occurring at 
relatively high levels (Figure 4).  However, by the time the oocyte leaves diplotene 
arrest RNA synthesis has declined to non detectable levels.  At this time ~60% of 
the RNA is rRNA, 30% is tRNA and 5% is mRNA (Schultz, 1986).  Even though 
transcription has ceased by this point translation continues using the stored RNA as 
machinery for building proteins.  This situation remains until the 2-cell stage in 
mouse embryos (8- to 16-cell stages in bovine embryo).  It is interesting to note 
that to our current knowledge genomic activation will usually occur two cell cycles 
before the morula begins to compact.  During this time, any qualitative or 
quantitative changes in protein synthesis occur irrespective to any transcriptional 
events (reviewed by Bachvarova, 1985).  There is evidence of selective activation 
of pre-existing mRNA, and extensive modification to post-translational proteins in 
response to external events (Braude et al., 1979; Howlett and Bolton, 1985; Van 
Blerkom, 1981).  At this stage, the embryo appears to be independent of any 
genomic control. 
 At the 2-cell stage in mouse embryos there is a qualitative change in protein 
synthesis that accompanies active transcription from the new embryonic genome 
(Bolton et al., 1984).  This resumption of transcription is accompanied by a 
massive degradation of the maternal-derived transcripts that have been controlling 
the development of the embryo up to this point.  This degradation of mRNA will 
release a vast amount of purines, and since there is little evidence of de novo purine 
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synthesis the relative levels of the purine salvage enzymes, adenine phosphoribosyl 
transferase and hypoxanthine phosphoribosyl transferase will have a tremendous 
impact on the metabolism of the developing embryo (Kochhar et al., 2001).         
X-chromosome Inactivation 
 Of central importance to this research is the developmental process known 
as X-chromosome inactivation.  During the growth phase of oogenesis, when the 
oocyte is arrested in diplotene, both X-chromosomes of the oocyte are 
transcriptionally active.  Once the oocyte resumes Meiosis-I RNA synthesis 
decreases to nondetectable levels.  Transcription of the maternal genome ceases 
after the first cellular cleavage in the mouse.  This is followed by transcription of 
the embryonic genome.  The embryonic genome contains both the maternal and 
paternal derived genetic components.  Even though transcription ceases during the 
early stage of development, translation continues utilizing the transcripts 
accumulated during the growth phase of oogenesis (Wassarman and DePamphilis, 
1993) (Figure 4). 
 Following the completion of Meiosis-I in the oocyte, one of the X-
chromosomes is extruded in the first polar body.  After fertilization and embryo 
genomic activation a female embryo has two transcriptionally active X-
chromosomes until X-chromosome inactivation commences at the blastocyst stage 
(Monk and Harper, 1979).  This can be contrasted to the one transcriptionally 
active X-chromosome in male embryos.  The inactive X-chromosome in the germ 
cells of females is reactivated prior to oogenesis, while the inactive X-chromosome 
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of somatic cells remains dormant (Monk and Kathuria, 1977; Kratzer and 
Chapman, 1981). 
 Thus, from the time of genomic activation until blastulation a female 
embryo will have twice the amount of hypoxanthine phosphoribosyl transferase 
than the male embryos (Monk and Harper, 1979). 
Hypoxanthine Phosphoribosyl Transferase 
 Hypoxanthine phosphoribosyl transferase (HPRT) is a purine salvage 
enzyme that catalyzes the reaction of phosphoribosyl pyrophosphate (PRPP) with 
hypoxanthine to form the nucleotide inosine monophosphate (IMP).  The reaction 
is diagramed in Figure 5.  Hypoxanthine phosphoribosyl transferase can catalyze 
the reaction with guanine in the place of hypoxanthine with the same kinetics 
(Figure 6).  For this reason hypoxanthine phosphoribosyl transferase is also known 
as hypoxanthine-guanine phosphoribosyl transferase (HGPRT) (Konecki et al., 
1982)  
 Hypoxanthine is a nontoxic intermediate in the catabolism of purine 
nucleotides (Figure 7).  If it is not acted on by hypoxanthine phosphoribosyl 
transferase it will be further degraded to uric acid by xanthine oxidase, a pathway 
that produces two moles of the reactive oxygen species hydrogen peroxide for each 
mole of hypoxanthine (Figure 2).  If hypoxanthine is acted on by hypoxanthine 
phosphoribosyl transferase, inosine monophosphate will be the product, which can 
serve as the precursor of adenosine monophosphate (AMP) and guanine 
monophosphate (GMP).  As stated earlier, there is an accompanying enzyme that 
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Figure 6. Hypoxanthine, adenine, guanine and phosphoribosyl pyrophosphate.
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Figure 7. Purine catabolism (Voet and Voet, 1990). 
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salvages adenine, adenine phosphoribosyl transferase, and converts it directly to 
AMP.   
 The mouse hypoxanthine phosphoribosyl transferase cDNA was originally 
isolated by Konecki et al. (1982). The mRNA is 1,292 base pairs in length.  It has 
an 87 base pair 5’ noncoding sequence preceding a 657 base pair open reading 
frame.  This is followed by 548 base pairs of a 3’ noncoding sequence that contains 
three polyadenylation signals, two of which are over lapping.   
 The open reading frame of the mouse hypoxanthine phosphoribosyl 
transferase mRNA codes for a 218 amino acid residue protein.  This protein is 
highly conserved in all mammals studied thus far, with greater than 95% homology 
(Jiralerspong et al., 1996). 
 The mouse hypoxanthine phosphoribosyl transferase gene is a 33 kilobase 
gene containing 9 exons and is located on the long arm (Xq26-q27) of the mouse 
X-chromosome (Shows and Brown, 1975). 
Hypoxanthine phosphoribosyl transferase is considered a housekeeping 
gene since it is expressed at detectable levels in every tissue.  There is evidence that 
hypoxanthine phosphoribosyl transferase is responsible for the majority of the 
purines in the brain (Jiralerspong et al., 1996).  Since hypoxanthine phosphoribosyl 
transferase is highly conserved and the sequence has been known for a long time, it 
is used often in mutation studies where any alteration of its sequence can be 
detected easily.  The hypoxanthine phosphoribosyl transferase gene has also proved 
useful in cell culture studies since its product is selectable.  Cells when cultured in 
medium containing HAT supplement (hypoxanthine, aminopterin, thymine) will 
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cease de novo purine and thymine production due to the aminopterin and will rely 
on the purine salvage enzyme hypoxanthine phosphoribosyl transferase for purines.  
If hypoxanthine phosphoribosyl transferase is not present in the cell, the cell will be 
missing purines and die (Freshney, 1987). 
Gout and Lesch-Nyhan Syndrome 
 Hypoxanthine phosphoribosyl transferase is associated with two diseases; 
gout and Lesch-Nyhan syndrome (Voet and Voet, 1990).  Gout is a disease 
characterized by excess production of uric acid in body fluids.  The most common 
manifestation is excruciating joint inflammation (most often in the big toes).  This 
is due to the deposition of uric acid crystals in the joints.  More seriously, uric acid 
crystals may be deposited in the kidneys causing renal damage and potentially life 
threatening renal failure.  The uric acid is accumulated through over activity of the 
xanthine oxidase pathway.  One cause of the over production of uric acid is a 
deficiency in hypoxanthine phosphoribosyl transferase, leading to less purine being 
salvage and more being degraded to uric acid.  This is one reason gout most often 
affects males,  it is, in the case of hypoxanthine phosphoribosyl transferase 
deficiency, a sex-linked genetic disease for which males are not fortunate enough to 
have an extra allele of the gene.  Gout is commonly treated by allopurinol 
administration.  The allopurinol is metabolized by xanthine oxidase to alloxanthine, 
which irreversible binds the xanthine oxidase inactivating it (Kelley, 1967; Voet 
and Voet, 1990). 
 Lesch-Nyhan syndrome is a distructive disease that is sex-linked and 
genetic (Lesch and Nyhan, 1964).  It is characterized by mental retardation and 
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grotesque self-mutilation.  Even though the exact method is still unknown it is 
caused by a complete lack of functional hypoxanthine phosphoribosyl transferase.  
The disease, does not present itself until a couple years of life when some self 
mutilation behavior, such as lip biting and eye gauging, is followed by a noticeable 
mental retardation.  The prognosis is not favorable for the afflicted individuals, and 
they tend to succumb to wounds or infections arising from the self mutilation 
behavior.  Very few survive to the teenage years.  Unfortunately, the individuals 
with the disease are not severely mentally retarded, invariablely present themselves 
with a pleasant happy character, and gravest of all appear to be well aware of the 
detrimental results of the acts of self mutilation. 
There has been a reported case of a female with Lesch-Nyhan syndrome 
(Hara et al., 1982).  The carrier females do not present any signs of the syndrome, 
even though some of their tissues lack hypoxanthine phosphoribosyl transferase 
activity due to random inactivation of the X-chromosome (Hara et al., 1982).  
Finally, knockout mouse models of the disease do not exhibit the self mutilation 
behavior, but do exhibit some signs of retardation (Dunnett et al., 1989).  These 
animals have not proven to be the ideal model system for the study of Lesch-
Nyhans syndrome, but they have been shown to be useful in the study of 
hypoxanthine maintained arrest of mouse oocyte maturation (Downs, 1997a). 
Hypoxanthine Phosphoribosyl Transferase and Development     
To date the majority of work with hypoxanthine phosphoribosyl transferase 
and development has centered on three areas: 1) oocyte maturation, 2) mouse 2-cell 
in vitro developmental block and 3) X-chromosome inactivation. 
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The latter area has mostly been concerned with the use of hypoxanthine 
phosphoribosyl transferase as a maker for X-chromosome inactivation (Monk and 
Harper, 1978).  Hypoxanthine phosphoribosyl transferase has never been 
implicated in any way with the mechanism of X-chromosome inactivation.  
However, its use as an indicator of X-chromosome inactivation has led to the 
revelation of some interesting relationships between, hypoxanthine phosphoribosyl 
transferase and embryo development that will be discussed here. 
It is apparent that hypoxanthine phosphoribosyl transferase is present and 
active in the embryo prior to genomic activation (Kratzer, 1983).  This of course 
leads to the correct assumption that the hypoxanthine phosphoribosyl transferase at 
this stage is a result of transcription of the maternal genome of the oocyte during 
oocyte maturation (Harper and Monk, 1978).  Similarly, there is evidence that 
hypoxanthine phosphoribosyl transferase is present and active in the embryos after 
genomic activation (Monk and Kathuria, 1977).  However, not only is this activity 
from the embryonic genome but it is clear that the level of activity is dictated by 
the number of X-chromosomes contained in the embryonic genome (Moore and 
Whittingham, 1992).   
Hypoxanthine phosphoribosyl transferase activity shows a slight increase 
from the time of oocyte maturation to the activation of the embryonic genome.  
Following genomic activation, however, hypoxanthine phosphoribosyl transferase 
begins to increase exponentially in the female embryos with male embryos on 
average having one-half the activity (Kratzer and Gartler, 1978; Kratzer, 1983).  In 
a population of mouse embryos the pattern of hypoxanthine phosphoribosyl 
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transferase expression will be bimodal until the late blastocyst stage, when the 
mode with the greater amount of activity begins to diminish until there is only one 
mode, indicating that X-chromosome inactivation has occurred.  Monk and Harper 
(1978) concluded that X-chromosome inactivation occurs during blastulation.  
Even though the majority of this work has been accomplished with mouse embryos, 
similar results have been found with other species, including bovine embryos 
(Bernardi et al., 1996; Gutierrez-Aden et al., 2000). 
Hypoxanthine phosphoribosyl transferase has also been extensively studied 
in its relation to the developmental arrest of 2-cell mouse embryos (2-cell in vitro 
developmental block).  Preimplantation mouse embryos of some strains exhibit a 
developmental arrest that occurs in G2 of the second or third cell cycle (Dienhart et 
al., 1997).  This developmental arrest is aggravated in vitro by the presence of 
hypoxanthine, and is dependent on the presence of glucose in the medium (Downs 
and Dow, 1991).  The in vitro developmental block can also be reversed by 
incubating the embryos with compounds that elevate cAMP levels.  This implies an 
antagonistic relationship between the products of the purine salvage pathways, 
AMP (a precursor of cAMP) from adenine and GMP from hypoxanthine (Voet and 
Voet, 1990).  Even though hypoxanthine phosphoribosyl transferase has been 
shown to play a role in the developmental arrest caused by hypoxanthine, the 
mechanism by which the products of hypoxanthine phosphoribosyl transferase are 
causing this in vitro developmental block have not, to date, been elucidated 
(Deinhart et al., 1997). 
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Finally, the role of hypoxanthine phosphoribosyl transferase in oocyte 
maturation has received much attention.  Hypoxanthine is a known component of 
follicular fluid and when added to oocyte maturation medium can cause them cease 
maturation (Downs, 1997b).  This inhibitory effect has been seen in many species. 
It is believed that the requirement of the substrate, phosphoribosyl pyrophosphate, 
by both adenosine phosphoribosyl transferase and hypoxanthine phosphoribosyl 
transferase is the underlying mechanism causing the arrest of oocyte maturation by 
hypoxanthine (Downs, 1997a).       
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THE EFFECT OF HYPOXANTHINE PHOSPHORIBOSYL 
TRANSFERASE ON MOUSE ADIPOSE AND AREOLAR CELL GROWTH 
 
Introduction 
 Hypoxanthine phosphoribosyl transferase (HPRT) is a purine salvage 
enzyme (Voet and Voet, 1990).   It is responsible for converting the purine 
degradation product, hypoxanthine, to inosine monophosphate, a precursor of 
adenosine triphosphate (ATP) and guanine triphosphate (GTP) (Konecki et al., 
1982).  The reaction catalysed by hypoxanthine phosphoribosyl transferase is the 
substitution of the 1’pyrophosphate (H2P2O7) group of phosphoribosyl 
pyrophosphate with hypoxanthine.  
 In the absence of HPRT hypoxanthine is degraded to uric acid by the 
enzyme xanthine oxidase.  This degradation of hypoxanthine produces two moles 
of the reactive oxygen species, hydrogen peroxide (H2O2) for each mole of 
hypoxanthine degraded (Jiralerspong et al., 1996). 
 Reactive oxygen species, such as hydrogen peroxide, can cause severe 
cellular damage to organelles and especially phospholipid membranes, if they are 
not acted on by superoxide dismutase and catalase for conversion to benign water 
(Rieger, 1992).  However, reactive oxygen species are also required for normal 
cellular function and growth, and in some cases have been shown to increase 
cellular metabolism (Shoal and Allen 1990).  Therefore, increased levels of 
hypoxanthine phosphoribosyl transferase could serve to protect the cell from 
damage, by preventing the production of hydrogen peroxide, while decreasing 
metabolism and growth. 
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  To determine the effect of hypoxanthine phosphoribosyl transferase on cell 
growth and health in culture this study is to compare the growth rates, cellular size 
and membrane integrity of two cell lines, one with the hypoxanthine 
phosphoribosyl transferase gene and one without the hypoxanthine phosphoribosyl 
transferase gene. 
 The HPRT-positive cell line was derived from mouse subcutaneous areolar 
and adipose tissue by Sanford et al. (1948), and was one of the first cell lines 
established for continuous cell culture.  These cells grow in the presence of HAT 
(hypoxanthine, aminopterin and thymine) supplementation and require fetal bovine 
serum for normal growth. 
 The HPRT-negative cell line was derived from the HPRT-positive cell line 
by Littlefield (1963), and is used for hybridoma production.  The HPRT-negative 
cells are sensitive to HAT supplementation and like the HPRT-positive cells 
require fetal bovine serum for normal growth. 
Materials and Methods 
Cell Lines 
 Two cell lines, one with hypoxanthine phosphoribosyl transferase activity 
(CCL-1.0) and one without hypoxanthine phosphoribosyl transferase activity 
(CCL1.4), were purchased from American Type Culture Collection (ATCC, 
Rockville, MD), and will be referred to here as HPRT-positive and HPRT-negative, 
respectively (Figure 8). 
 The HPRT-positive cell line was derived from the subcutaneous areolar and 
adipose tissue of a 100-day-old male C3H/An mouse in 1948 and is one of the first 
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Figure 8.  The  HPRT-positive (upper) and HPRT-negative cells (lower) (20X 
objectives).   
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cell lines established in a continuous culture system (Sanford et al., 1948).  The 
HPRT-negative cell line was isolated from the HPRT-positive cell line by 
Littlefield (1963).  They are deficient in the HPRT gene making them sensitive to 
HAT (hypoxanthine, aminopterin and thymidine) selection.  The sensitivity and 
insensitivity of the HPRT-negative and HPRT-positive cell lines was confirmed 
prior to this experiment by culture for 3 days in the presence of HAT 
supplementation (data not shown). 
 The cell lines prior to the start of this experiment were maintained in 75 cm2 
(Falcon) tissue culture flasks with 7.5 ml of Debeccules Modified Eagle’s Medium 
(DMEM, Gibco, Bethesda, MD) supplemented with 5% fetal bovine serum at 37oC 
in 5% CO2 air.  The cultures were passaged every 3 days by removing the 7.5 ml of 
DMEM and adding 5 ml of 0.01% Trypsin-EDTA (Gibco, Bethesda, MD).  The 
cells were allowed to detach for 5 minutes at room temperature.  A 4.5-ml volume 
of the resulting cell suspension was disposed of and to the remaining 0.5 ml of cell 
suspension 7 ml of DMEM was added and the flask returned to the 37oC and 5% 
CO2 in air. 
Experimental Design 
 A total of 500,000 cells of either the HPRT-positive (Treatment A) or 
HPRT-negative (Treatment B) cell line was used to seed 25 cm2 tissue culture 
flasks.  This seeding was replicated 5 times.  The cells were incubated in 3 ml of 
DMEM with 5% fetal bovine serum at 37oC and 5% CO2 in air.  Every 48 hours for 
480 hours the cells were incubated (the cultures were between 90 and 95% 
confluent at each passage) and data were collected. 
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 The 3 ml of DMEM was removed and 3 ml of 0.01% Trypsin-EDTA 
(Gibco, Bethesda, MD) was added and allowed to stand at room temperature 
(25oC) until all cells had detached, which was confirmed by observation with a 
Nikon inverted Diaphot microscope at 100X magnification.  All but 0.5 ml of the 
0.01% Trypisin-EDTA cell suspension (between 178,000 and 611,000 cells) was 
removed to which 2.5 ml of DMEM was added and the cultures returned to the 
incubator for the next 48 hours. 
 The remaining 2.5 ml of the 0.01% Trypsin-EDTA cell suspension was 
used to obtain the mean cell diameter, membrane integrity and cell counts.  These 
counts were made using a Improved Neubauer hemacytometer at 100X 
magnification on a Nikon inverted Diaphot microscope.  The procedure used for 
counting cells in vitro has been previously reported by Freshney (1987).  The 
equation used to determine the number of cells is as follows: 
      Cell Count = (no. of cells counted) (1 x 104) ÷ (4) (volume of cell suspension) 
The mean number of cells at each passage/culture flask, as well as the increase in 
cell number/flask was then determined every 48 hours. 
The mean cell diameter was determined by photographing 10 µl of the cell 
suspension place on a glass slide with a Nikon inverted Diaphot microscope with 
20X objectives and a Cannon SLR 35 mm AE1 camera using 400 ASA 
KodaChrome color slide film.  After development of the film the images were 
scanned using a Microtek 35t color slide scanner at 200 dpi.  The mean diameter of 
the cells was determined using measure tool of Adobe Photoshop 5.0 that had been 
calibrated with a stage micrometer.  Measurements for the mean diameter for each 
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cell line at each passage were determined by averaging the diameters of 2 axes 
from three randomly chosen cells.  This was replicated 5 times with each cell line. 
The membrane integrity was determined by adding 2 µg of propidium 
iodide (Sigma, St. Louis, MO) and 2 µg of Hoechst 33324 (Sigma, St. Louis, MO) 
to 100 µl of the cell suspension.  Propidium iodide will only fluoresce red when 
bound to the nuclear DNA of cells with compromised membranes that do not 
exclude the dye.  Hoechst 33342 will bind to the nuclear DNA of cells with and 
without intact membranes and fluoresce blue.  Cells with both propridium iodide 
and Hoechst 33324 fluorescence have a color slightly on the orange side of red.  
The cells were photographed using the procedure stated above but with ultraviolet 
illumination.  The percent of cells with intact membranes were then determined by 
counting the 10 cells nearest the upper left hand corner of the scanned developed 
film.  As stated in the results section the photographing of the fluorescent cells was 
ceased at the third passage, however, visual observation of the cells using a Nikon 
Diaphot microscope with 20X objectives was continued. 
Statistical Analysis 
An analysis of variance was used to detect significant differences in the 
mean number of cells, increase in cell number and mean cell diameter at each 
passage (Freshney, 1987).  A simple regression model was used to determine the 
differences in growth between cell lines over the course of the experiment 
(Freshney, 1987). 
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Results 
For the first three subpassages there was not a difference in the membrane 
integrity because none of the cells in the photographs were flourescening orange as 
would be expected with propidium iodide and Hoechst 33324 staining.  Further 
investigation at the fourth subpassage revealed that there were less than 10 
cells/100,000 cells with compromised membranes.  This led to cessation of the 
photographing after the third subpassage, however, the cells were observed visually 
for the remainder of the experiment.  
The mean cell number/cell line at each subpassage is presented in Figure 9.  
There was a significant difference in the number of cells at the first, second, ninth 
and tenth subpassages (P<0.05).   There was not a significant difference in the 
mean number of cells at each 48-hour subpassage within cell lines.  The growth 
rates of the two cell lines (Treatment A and Treatment B) were not significantly 
different.  The increase in cell number between the two cell lines (Treatment A and 
Treatment B) at each subpassage is significantly different (P<0.05) at the first two 
and last two subpassages (Figure 10).   
There was not a significant difference in the mean cell diameter measured at 
any subpassage (Figure 11).  The mean cell diameter at the first subpassage was   
30 µ (Treatment A) and 36.3 µ (Treatment B).  The mean cell diameter at the last 
subpassage was 24.5 µ (Treatment A) and 28.4 µ (Treatment B). 
Discussion 
 Mouse HPRT cDNA was isolated by Konecki et al. (1982).  The mRNA has 
a 87 base pair 5’ noncoding sequence situated upstream of the 657 base pair open 
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Figure 9.  The mean number of cells (±SE) at each passage for the HPRT-positive 
and HPRT-negative cell lines. 
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Figure 10.  The mean (±SE) increase in cells at each subpassage for the HPRT-
positive and HPRT-negative cell lines. a,bBars with different superscripts are 
significantly different (P<0.05). 
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Figure 11.  The mean (±SE) cell diameter of the HPRT-positive and HPRT- 
negative cells. 
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reading frame.  There are 548 base pairs of a 3’ noncoding sequence that contains 
three polyadenlylation signals.  Two of the polyadenylation signals are 
overlapping.  The mRNA is 1,292 base pairs in length (Konecki et al., 1982). 
 The HPRT protein, coded from the open reading frame, has 218 amino acid 
residues.  In all mammals studied thus far the protein is highly conserved, with 
greater than 95% homology (Jiralerspong et al., 1996). 
 The gene for HPRT contains 9 exons and is located on the long arm (Xq26-
q27) of the mouse X-chromosome.  The HPRT gene is 33 kilobases in length 
(Shows and Brown, 1975). 
 HPRT is responsible for the majority of purines produced in the brain 
(Jiralespong et al., 1996).  Mutations of the HPRT gene is responsible for two 
diseases; Lesch-Nyhan syndrome and gout (Lesch and Nyhan, 1964; Kelly, 1967). 
HPRT can alter the reactive oxygen specie content of cells by effecting the 
activity of the pentose phosphate pathway and shifting the metabolism of purines 
away from the reactive oxygen specie producing purine degradation pathway 
(Jiralerspong et al., 1996).  However, HPRT can have a more direct action on the 
metabolism of cells by altering the relative abundance of ATP and GTP (Konecki 
et al., 1982). 
Based on the data from the membrane integrity potion of this experiment, 
the absence of HPRT is not causing any detectable damage to the cell lines used in 
this study.  This is surprising since the work of Sohal and Allen (1990) indicates 
that the absence of HPRT should result in significant membrane damage.  HPRT is 
known to effect the reactive oxygen species content of cells (Rieger, 1992).  It is 
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possible that the dye exclusion technique used here is not sensitive enough to detect 
a difference in reactive oxygen species damage.  
 Several groups have reported differences in the growth rates of mammalian 
embryos with male embryos developing faster (Avery et al., 1991; Callesen et al., 
1995; Tarin et al., 1995).  The activity of HPRT in mouse embryos prior to X-
chromosome inactivation is associated with the sex of the embryo (Monk and 
Harper, 1978).  Female embryos have twice the amount of HPRT activity than male 
mouse embryos (Monk and Kathuria, 1977).  This association of embryo sex and 
HPRT activity has also been reported with bovine embryos (Gutierrez-Adan et al., 
2000). 
 An alteration in the rate of growth between male and female pig embryos 
was reported by Cassar et al. (1994).  This alteration in the growth of pig embryos 
was seen when comparing the embryos before and after hatching.  Xu et al. (1992) 
observed faster development of the blastocoel in male bovine embryos  compared 
with female bovine embryos.  Similar results were seen by Avery et al. (1989) with 
bovine embryos.  This finding was supported by the same group with IVF-derived 
embryos (Avery et al., 1991).  Avery et al. (1992) confirmed the results of these 
previous experiments. The male IVF-derived bovine embryos in the latter study 
formed blastocoels faster than the female embryos. 
 The faster rate of male embryo development has been attributed to the 
activity of the Y-chromosome by several studies (Avery et al., 1989; Avery et al., 
1991; Avery et al., 1992).  However, Xu et al. (1992) indicated that the difference 
in the rate of growth of male embryos compared with female embryos was due to 
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the activity of two X-chromosomes in the female embryos.  This stance has also 
been taken by Callesen et al. (1995).   
 Studying bovine embryos, Bredbacka and Bredbacka (1996) indicated that 
HPRT is the gene responsible for the faster growth of male embryos.  In addition, 
Bredbacka and Bredbacka (1996) claimed that the faster rate of growth of the male 
embryos was a consequence of the effect of HPRT on the reactive oxygen species 
content of the cell.  This view was supported by the same group with mouse 
embryos (Peippo and Bredbacka, 1995).  Similarly, Gutierrez-Adan et al. (2000) 
have advocated the effect of HPRT on the reactive oxygen species content of 
embryo cells as the cause of faster male bovine embryo growth. 
In the current study an effect of HPRT activity on the mean cell diameter 
was not detected.  This could be the result of the limited numbers of cells measured 
or this could reflect the limitation of the techniques used to determine the cell 
diameter.  This was an unexpected finding based on the results of Bredbacka and 
Bredbacka (1996). 
There was not a consistent difference in the mean number of HPRT-positive 
cells compared with HPRT-negative cells during the course of this experiment.  
This finding, taken with the other finding of this experiment (that HPRT does not 
effect cell diameter), indicates that HPRT does not have an effect on hyperplasia or 
hypertrophy of the HPRT-positive or HPRT-negative cells used in this experiment.   
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OVER EXPRESSION OF THE HPRT GENE IN PREIMPLANTATION 
MOUSE EMBRYOS ALTERS THE EXPECTED SEX RATIO AND 
HINDERS BLASTOCEOL FORMATION 
 
Introduction 
 In domestic animal embryo transfer practices, it is common to lack recipient 
females for embryo transfer.  Similarly, in human IVF programs the state of 
recipient uterus can not be dictated.  Therefore, the ability to dictate the rate of 
preimplantation embryo development has implication for human IVF programs. 
Other fields, such as experimental mouse embryo production and bovine embryo 
transfer, will also benefit from the greater control of embryo development. 
 There is evidence that sexual dimorphism exists in preimplantation 
embryos.  This has been reported in mice (Valdivia et al., 1993; Tusonda et al., 
1985), cattle (Avery et al., 1989; Avery et al., 1991; Avery et al., 1992), pigs 
(Cassar et al., 1994) and humans (Tarin et al., 1995).  In these studies, male 
embryos tended to have faster blastocoel formation.  While some groups (Tusonda 
et al., 1985; Avery et al., 1989) have proposed a Y-chromosome factor as the agent 
of accelerated male development, others indicate that the increased expression of 
X-linked genes prior to X-chromosome inactivation retards the female embryos 
(Bredbacka and Bredbacka, 1996; Bredbacka, 2001).  Even though sexual 
dimorphism of preimplantation embryos is likely due to the action of multiple 
genes, the elucidation of only one of the genes leading to the altered developmental 
rates may allow extraneous control of development by control of the endogenous 
gene. 
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The present study was undertaken to determine if the X-linked gene 
hypoxanthine phosphoribosyl transferase (HPRT) has an effect on the rate of 
embryo development.  Hypoxanthine phosphoribosyl transferase converts the 
purine degradation product hypoxanthine to inosine thereby, bypassing the 
xanthine oxidase pathway that increases reactive oxygen species (H2O2) levels, 
effectively lowering the oxygen radical content of the cells (Sohal and Allen, 
1990).  The fact that oxygen radicals may stimulate growth as reported by Reiger 
(1992) has lead Peippo and Bredbacka (1995) to speculate that the cellular effect of 
HPRT may be responsible for the sexual dimorphism of preimplantation embryos. 
 The first model of blastocoel formation was proposed by Melissinos (1907).  
This model was founded on the coalescence of refractile droplets in mouse 
embryos.  Ducibella and Anderson (1975) presented a model of blastocoel 
formation based on the presence of tight junctions formed by the outer blastomeres 
of compacted mouse morulae and the movement of ions from the extra-embryonic 
space to the blastocoel.  The currently accepted model states that lipids in the outer 
blastomeres undergo beta-oxidation to form ATP (Wiley, 1984).  This ATP is used 
to drive Na+/K+ ATPases in the basolateral membrane of outer blastomeres.  This 
increases the amount of Na+ in the blastocoel causing a flow of water into the 
blastocoel with the resulting increase in blastocoel size.   
While research has been conducted on hypoxanthine phosphoribosyl 
transferase, its actions on oocytes maturation and the mouse 2-cell block, the effect 
of this gene on compaction and blastulation has not been extensively studied 
(Dienhart et al., 1997; Downs and Dow, 1991; Downs et al., 1998).  This study uses 
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transgenic mouse embryos over expressing HPRT to determine if this gene has an 
effect on the sex ratio and development of mouse embryos. 
Materials and Methods  
HPRT Expression Construct 
 The full length mouse HPRT cDNA (Konecki et al., 1992, ATCC #37424) 
was positioned downstream of the phosphoglycerate kinase (PGK) promoter 
(Figure 12).  Briefly, the agouti fragment was excised from the PGK-agouti 
plasmid (Klebig et al., 1995) by PstI digestion and replaced with a PstI fragment 
containing the full length mouse HPRT cDNA.  The PGK promoter was selected 
due to its known endogenous ubiquitous expression during all stages of 
preimplantation development (Monk, 1987).  Correct orientation of the HPRT 
cDNA was determined by HindIII digestion and the plasmid designated 
pLSUMC2.0(+). 
Transgenic Mice 
 The EcoRI-ApaI fragment of pLSUMC2.0(+), containing the PGK 
promoter, HPRT cDNA and PGK polyadenylation signal (HPRT transgene), was 
injected into the pronucleus of FVB/N sperm-exposed ovum and transgenic mice 
derived as described by Hogan et al. (1994) (Figure 13).  
Briefly, the HPRT transgene at a concentration of 3 ng/ml of Tris-EDTA 
(pH 8.0) was injected into one of the two pronuclei of the FVB/N sperm-exposed 
ovum (The sperm-exposed ovum were collected from mice, from Jackson 
Laboratories, that were between 4 and 8 weeks-of-age and were maintained on 
Purina rodent chow (Sigma, St. Louis, MO) at 4 or less mice/cage.) by holding the 
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Figure 12.  The pLSUMC2.0(+) construct. 
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Figure 13. The HPRT transgene construct. 
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ovum with a micromanipulator equipped with a holding pipette.  The HPRT 
transgene was then injected into the pronucleus by passing the injection pipette     
(< 1.0 µ diameter) through the zona pelucida, oolemma and pronuclear membrane.  
Positive pressure was applied until the pronucleus had expanded by at least twice 
the original size.  The injection pipette was then removed from the embryo and 
following overnight culture under the conditions described herein.  The surviving 
embryos were transferred to the oviducts of CD-1 mice mated to vasectomized 
male FVB/N mice.  Live pups were weaned 21 days following birth and genotyped 
using the Maxi-Prep Kit (Quiagen, Rheimstein, Germany).   
RNA (Northern) Blot Analysis 
 Northern-blot hybridization analyses was performed as described by 
Ausudel et al. (1989) on total RNA from the gonads, liver, heart and brain of adult 
transgenic (Tg/-) mice and nontransgenic littermates of both sexes for comparison.  
The liver, heart and brain were selected as representative tissues of each embryonic 
germ layer (endoderm, mesoderm and ectoderm, respectively).  The full length 
mouse HPRT cDNA referenced above was used as a probe. 
Embryo Collection and Culture Conditions  
 Female FVB/N mice were primed with 5 IU of equine chorionic 
gonadotropin (Sigma, St. Louis, MO), followed by 5 IU of human chorionic 
gonadotropin (Sigma, St. Louis, MO) 46 hours later.  Following administration of 
human chorionic gonadotropin the females were placed with male mice 
hemizygous for the HPRT transgene.  The male mice were derived from one of two 
lines TgN(HPRT)ARlm (referred to as HPRT-A) and TgN(HPRT)BRlm (referred 
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to as HPRT-B) resulting from a pronuclear injection procedure.  All animals were 
maintained on a 12-hour light-dark cycle with coitus calculated to be at 12:00 pm.  
The following morning sperm-exposed ovum were isolated from females exhibiting 
vaginal plugs. The embryo collection was performed by sacrificing the animals by 
cervical dislocation and removing the oviducts.  The oviducts were placed into 
M16 medium (Hogan et al., 1994; Sigma, St. Louis, MO) and the cumulus cell 
masses removed with a 26-gauge needle.  Embryos obtained from the same lines 
were pooled for each replicate. 
 Following collection the embryos were incubated 24 hours in 100 µl of M16 
medium (Sigma, St. Louis, MO).  After 24 hours, the embryos were transferred to 
100 µl of M16 medium with 4 mg/ml of bovine serum albumin (BSA, Fraction-V, 
Sigma, St. Louis, MO) for a additional 24 hours in culture.  At that time point (48 
hours after embryo collection) any embryo exhibiting signs of compaction were 
placed into individual droplets of M16 medium with 4 mg/ml of BSA.  The 
medium was changed at 24-hour intervals for the remainder of culture.  Embryos 
were cultured at 5% CO2 air and 37oC. 
Embryo Evaluation 
 Beginning 72 hours post-coitum (pc) embryos were assigned a Collins-RED 
score (C-RED), which is based on morphology of development (Tables 1 and 2).  
The C-RED score was adapted for use with mouse embryos from the RED score 
reported by Ryan et al. (1992) for use with in vitro culture of bovine embryos. 
The degree of development for compacted morula was based on the extent 
cell membrane contact; with a degree of 4 exhibiting no contact and 1 complete cell 
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smoothing.  An early blastocyst was assigned to an embryo based on the presence 
of a blastoceol that was not greater than 50% the volume of the embryo.  A degree 
of 4 was considered to have a cavitated while a degree of 1 had a blastoceol making 
up 50% the volume of the embryo.  If the blastoceol was greater than 50% the 
volume of the embryo a blastocyst state was assigned.  The expanded blastocyst 
state fit any embryo whose blastoceol was the vast majority of the volume of the 
embryo and there was evidence of zona pellucida thinning.  A degree 3 hatching 
blastocyst was assigned any embryo that exhibited signs of hatching with less than 
50% of the embryo outside the zona pellucida.  Likewise, a degree 2 hatching 
blastocyst was considered to be any embryo greater than 50% hatched but not 
completely free of zona pellucida.  A degree 1 hatched blastocyst was any embryo 
completely zona pellucida free. 
The C-RED score can be described by the formula Yij = µ + φi + φj, where 
Yij = the C-RED score for an embryos at the ith state of development and the jth 
degree of development, µ = the overall mean C-RED score for the embryos, φi = Yi 
– µi and φj = Yj – µj. 
Embryo Diameter 
 At 128 hours pc, any embryo that had cavitated was photographed using a 
Nikon TE-200 inverted microscope with 40X objectives and a Cannon SLR 35 mm 
AEI camera using 400 ASA KodaChrome color slide film. 
 Following development of the film, the embryo images were scanned using 
a color slide scanner (Microtek 35t)  at 200 dpi.  The embryo diameter (the mass of 
blastomeres including the blastocoel, but exclusive of the perivitelline space and 
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the zona pellucida) was determined using the measure tool of Adobe Photoshop 5.0 
that had been calibrated with a stage micrometer.  Measurements for each embryo 
were taken on 3 axes and averaged to calculate the embryo diameter. 
HPRT Microassay, Embryo Sex and Genotype Determination 
 Following photomicroscopy individual embryos were washed 3 times 
through phosphate-buffered saline containing 4 mg/ml polyvinylpyrrolidone (PBS-
PVP).  They were then individually transferred to 0.5-ml Eppendorf 
microcentrifuge tubes with 12 µl of PBS-PVP solution and frozen at -70oC until 
assay. 
 A 4-µl volume of the PBS-PVP solution was assayed for HPRT activity 
using the method described by Downs and Dow (1991).  The HPRT assay was 
validated with a time course using three assays of 4-cell embryos at 3-hour 
intervals for 12 hours.  In addition, a standard curve was plotted with each assay 
using known amounts of HPRT (hypoxanthine-guanine phosphoribosyl transferase, 
Sigma, St. Louis, MO). 
 A 10-µl volume of lysis buffer (50 mM KCL, 10 mM Tris-Cl, pH 8.3, 
0.45% Nonidet P-40 and 0.45% Tween 20) with 100 µg of proteinase K was added 
to the remaining 8 µl of the embryo lysate and incubated at 55oC for 1 hour 
followed by incubation at 99oC for 10 minutes. 
 PCR to determine the sex of the embryo was performed using 9 µl of the 
above embryo sample as template.  The PCR consisted of 1X PCR buffer, 200 µg 
of dNTP’s (Gibco, Bethesda, MD), 2.5 units of Taq polymearse (Gibco), 150 mM 
MgCl and 1,000 nM of each oligonucleotide primer described  by Aansen and 
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Medrano (1990) and designed to amplify a 450 base pair region of the mouse 
ZFX/ZFY gene.  The reactions were thermocycled in a PTC-150 minicycler (MJ 
Research, Washington, DC).  The thermocyler profile consisted of 5 minutes at 
95oC; followed by 50 cycles of 1 minute at 95oC, 1 minute at 55oC and 1 minute at 
72oC and a final 10 minutes at 72oC.  Then 0.1 µl of this reaction was used as the 
template in a subsequent PCR using primers mgc02-28-1b and 2b.  The reaction 
conditions were identical to that above, and the only alteration in thermocycling 
parameters was the substitution of 35 cycles for 50 cycles.  A 15-µl volume of the 
resulting reaction was digested to completion with HaeII restriction endonuclease 
in a 20-µl total volume at 37oC. 
 The remaining 9 µl of embryo sample was used as a template in a PCR with 
primers, mgc02-10-3b and mgc02-10-4b, specific for the HPRT transgene.  The 
reaction conditions and thermocycle parameters were the same as above.  Primer 
sequences unique to this study are listed in Table 3. 
 The resulting sex determination and embryo genotyping products were 
resolved in a 3% agarose gel (SeaKem, FMC, Portland, ME).   The fragments were 
visualized by ethidium bromide fluorescence using ultraviolet illumination. 
 The PCR assays were validated prior to embryo sex and genotype 
determination by diluting known genomic DNA to a concentration of 12.5 pg/µl 
and treating 8 µl of the genomic DNA similar to the embryo lysate above.  
Genomic DNA samples of each sex and genotype were run with each assay to serve 
as positive controls.  Negative controls to detect contamination consisted of the 
embryo lysis buffer without embryo or genomic DNA samples. 
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Experimental Design 
 This experiment was designed to determine if the HPRT transgene will alter 
the sex and genotype ratios of mouse embryos.  Therefore, any significant 
deviation from the expected 25% male nontransgenic will be taken as an indication 
of HPRT alteration of the sex and genotype ratios.  A total of 34 mice were used 
for RNA collection from the gonads, livers, hearts and brains. 
Statistical Analysis   
 The deviation of sex and genotype from the expected was tested for 
statistical significance by Chi-square analysis.  An analysis of variance for repeated 
measures was used to examine the effects of time and sex and genotype of the 
embryos on the C-RED score.  The correlation of sex and genotype with HPRT 
activity was tested using a standard regression model.  The relationship of HPRT 
activity, sex and genotype with the embryo diameter was analyzed using a general 
linear model.  All statistical procedures were performed using version 8.0 of the 
SAS software for windows (Stokes et al., 1995). 
Results 
 Thirteen donors (5 mated to HPRT-A males and 8 to HPRT-B males) 
yielded 282 embryos over 6 replicates.  Of these embryos, 77.3% survived culture 
to the 2-cell stage, 60.3% reached the 4-cell stage, resulting in 138 morulae.  There 
was no detectable difference in embryo development between lines.  Of the 124 
embryos surviving culture to the blastocyst stage, 51 were derived from line HPRT-
A and 73 from line HPRT-B.  PCR data were collected on 105 of the 124 
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blastocysts.  PCR failure in all cases is attributed to sample loss prior to analysis 
since all embryos failing to produce PCR products also failed to yield HPRT 
activity.  Only C-RED scores from embryos with known sex and genotypes were 
used in the analysis. 
 Adult mice that were hemizygous for the transgene (Tg/-) were examined 
for increased expression of HPRT versus nontransgenic littermates (+/+) (Figure 
14).  As expected, there were increased levels of HPRT mRNA in the organs 
examined from the transgenic mice.  However, female nontransgenic mice appear 
to have greater amounts of HPRT mRNA in the heart tissue compared with the 
heart tissue in the transgenic animals.  Similarly, the males of HPRT-A showed 
lower levels of HPRT mRNA in the brain tissue compared with the brain tissue of 
the nontransgenic mice.  Transgenic mice of both lines and sexes have increased 
HPRT mRNA levels in the gonads.  As with the increased mRNA levels, there was 
a highly significant effect of sex and genotype on the HPRT activity of the embryos 
(P<0.01), with the female transgenic embryos having mean HPRT activity of 2.63 
pmol/hour/embryo compared with only 0.62 pmol/hour/embryo and 0.93 
pmol/hour/embryo for the female nontransgenic and male transgenic embryos.  As 
expected, the male nontransgenic embryos had the lowest mean HPRT activity 
(0.38 pmol/hour/embryo).  The mean HPRT activity is presented in Figure 15. 
 Of the 105 embryos from which PCR sex and genotype data were collected, 
68 (65%) were male and nontransgenic, 19 (18%) were male and transgenic, 13 
(13%) were female and nontransgenic and 5 (5%) were female transgenic embryos.  
This ratio of sex and genotype were significantly different from the expected 
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Figure 15.  The mean HPRT activity (±SE) of mouse blastocysts overexpressing 
HPRT.  Female transgenic (F/Tg), female nontransgenic (F/+), male transgenic 
(M/Tg) and male nontransgenic (M/+).  a,bBars with different superscripts are 
significantly different (P<0.05). 
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(P<0.05, χ2-test).  The two mice lines (HPRT-A and HPRT-B) currently have a live 
birth sex ratio of 53.1% and 47.6% males, respectively, and a genotype ratio of 
47% and 44.8% positive, respectively. 
 The level of HPRT activity could not be correlated with the embryo 
diameter (Figure 16).  However, there was a significant effect (P<0.05) of sex on 
embryo diameter.  Male embryos had a larger mean diameter with 106.4 µ 
compared with 98.4 µ for the female embryos. 
 There was a significant effect of embryo genotype and sex over time on the 
assigned C-RED scores (P<0.05).  Mean C-RED scores for embryos of different 
sex and genotype are presented in Figure 17.  There was no difference in C-RED 
scores between embryo groups at 72 hours pc.  At 80 to 96 hours pc female 
transgenic embryos tended to plateau, while the embryo of the opposite sex and 
genotype showed increased development.  This produced a significant positive 
effect of sex and genotype at 96 hours pc (P<0.01).  However, by 104 hours pc the 
lagging female transgenic embryos had increased from the previous C-RED score.  
This trend continued until 112 hours pc, after which there was a decline in C-RED 
score for female transgenic embryos producing a significant negative effect 
(P<0.001) of sex and genotype at 128 hours pc. 
Discussion 
 The sex ratio of, 83% male compared with 18% female, reported in this 
study are supported by reports on other animals from other laboratories.  Avery et 
al. (1989) reported a significant difference in the development of bovine embryos at 
the blastocyst stage.  In this study, male embryos reached the blastocyst stage 
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Figure 16.  The mean embryo diameter (±SE) of FVB/N mouse blastocysts 
overexpressing HPRT.  a,bBars with different superscripts are significantly different 
(P<0.05).
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Figure 17.  Mean Collins-Ryan Embryo Development (C-RED) scores for mouse 
blastocysts overexpressing HPRT. Female transgenic (F/Tg), female nontransgenic 
(F/+), male transgenic (M/Tg) and male nontransgenic (M/+). 
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before female embryos.  The presence of the Y-chromosome in male embryos was 
considered to be responsible for the faster rate of development.  Similar findings 
were later reported by the same group, again with bovine embryos (Avery et al., 
1991). 
 Valdivia et al. (1993), studying the sex differences of mouse embryos, 
determined that male embryos formed a blastocoel before female embryos.  This 
was attributed to the activity of two X-chromosomes of female embryos.  Male 
mouse embryos had a greater rate of cleavage than female mouse embryos in a 
study by Peippo and Bredbacka (1995).  Tusonda et al. (1995), also working with 
mouse embryos, detected an alteration in the rate of blastomeres cleavage between 
male and female embryos.  Similar results were noted by Cassar et al. (1994) while 
studying pig embryos.  In that study an alteration between male and female pig 
embryos was reported in the rate of growth, before and after hatching.  Xu et al. 
(1992) also showed a difference in development rates of bovine embryos.  Male 
bovine embryos developed faster than female bovine embryos in the latter report.     
 Konecki et al. (1982) isolated the mouse HPRT cDNA and reported that the 
mRNA was 1,292 base pairs in length.  There is a 87 base pair 5’ noncoding region 
situated upstream of the 657 base pair open reading frame.  The open reading frame 
precedes a 548 base pair 3’ noncoding sequence.  There are two polyadenylation 
signals overlapping in the 3’ noncoding sequence.  An additional polyadenylation 
signal is present.  The HPRT mRNA codes for a 218 amino acid protein.  In all 
animals studied thus far the protein is highly conserved (Jiralerspong and Patel, 
1996).   
 64 
As expected, in the present study there was increased HPRT mRNA levels 
were detected in the brain, liver and gonads of mice overexpressing HPRT.  Higher 
levels of HPRT mRNA from the HPRT promoter were found in the heart.  
However, the HPRT microassay demonstrates that the embryos positive for the 
HPRT transgene have increased levels of HPRT activity compared with the control 
embryos of the same sex.  This validates the mouse embryos used in this study as a 
model of the effects of overexpression of HPRT in preimplantation mouse 
embryos. 
 This is the first report of a genotype ratio for a HPRT transgene in mouse 
blastocysts.  The genotype ratio of 78% nontransgenic compared with 22% 
transgenic indicates that HPRT is involved in the sexual dimorphism of mouse 
embryos. Other studies have implied that HPRT may be involved in the altered sex 
ratios of both murine and bovine embryos (Peippo and Bredbacka, 1995; 
Bredbacka and Bredbacka, 1996).  Unlike the present study, the latter reports did 
not provide direct experimental evidence that HPRT altered the sex ratio.   
The C-RED score results indicate that embryos with higher HPRT activity 
develop a blastocoel later than those embryos with lower HPRT activity.  However, 
this was only detected in the female transgenic embryos.  The female transgenic 
embryos have HPRT levels that are greater than the highest HPRT levels found in 
embryos from nontransgenic mice (Kratzer, 1983).  Therefore, the C-RED scores 
could be revealing an effect of HPRT that is unique to the HPRT transgenic mouse 
embryos. 
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It was concluded by Jiralerspong and Patel (1996) that there was not an 
apparent mechanism for HPRT involvement in blastoceol formation.  Following 
genomic activation and degradation of maternal RNA, it is possible that the 
increased levels of purines in female embryos are converted more rapidly to GMP 
by HPRT (Bachvarova and Deleon, 1980).  This would lead to the creation of less 
AMP via the adenosyl phosphoribosyl transferase (APRT) pathway due to the 
accompanied decrease in phosphoribosyl pyrophosphate levels.  This would result 
in a decrease of ATP available in the presumptive trophectoderm for use by the 
Na+/K+ ATPase for blastoceol expansion (Fleming, 1992). 
 The lack of effect of HPRT activity on embryo diameter while sex has an 
influence demonstrates that sexual dimorphism of preimplantation embryos is 
likely due to multiple gene products, not only to HPRT.  In addition, this measure 
is only reflective of the contribution of embryo diameter to the stage of embryo 
development and the resulting sex related growth rates. 
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OVEREXPRESSION OF THE HPRT GENE IN MOUSE EMBRYOS AND 
THE NUMBER OF BLASTOMERES IN BLASTOOCYSTS 
 
Introduction 
 Avery et al. (1989) determined that there was a disparity in growth rates 
between male and female bovine embryos.  In this report male embryos reached the 
blastocyst stage faster than female embryos.  This was attributed to the presence of 
the Y-chromosome in male embryos.  Avery et al. (1991) detected a faster 
development of male bovine embryos to the blastocyst stage compared with female 
embryos.  The faster development of the male embryos was again attributed to the 
Y-chromosome in the male embryos. Similarly, Avery et al. (1992) considered the 
presence of the Y-chromosome to alter the growth of bovine embryos.  In this 
study, male embryos formed a blastocoel faster than female embryos. 
Bredbacka and Bredbacka (1996) detected a faster development to the 
blastocyst stage between male and female bovine embryos.  The report suggested 
that the presence of two X-chromosomes in the female embryos was the cause of 
the altered rates of growth.  Previously, Peippo and Bredbacka (1995) reported a 
faster rate of blastomeres cleavage with mouse embryos.  In this study, the male 
mouse embryos increase the number of blastomeres at a faster rate than the female 
embryos.  This result was also attributed to the activity of two X-chromosomes in 
the female embryos. 
 The disparity of growth between female and male embryos has been 
expressed in different ways.  Some studies compared the percentage of female to 
male embryos reaching a particular stage of development of bovine embryos 
(Avery et al., 1991; Avery et al., 1992;  Callesen et al., 1995; Grisart et al., 1995).  
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Other studies chose to ascertain the differences in morphological development 
based on size or time of cavitation of bovine embryos (Carvalho et al., 1996; 
Hochman et al., 1996).  Further studies considered the increase in the number of 
blastomeres as an indication of greater development of mouse embryos (Valdivia et 
al., 1993; Peippo and Bredbacka, 1995). 
 Hypoxanthine phosphoribsyl transferase (HPRT) is an X-linked gene 
(Konecki et al., 1982) that is responsible for the salvage of the purines, 
hypoxanthine and guanine (Voet and Voet, 1990).  HPRT is active in mouse 
embryos (Monk and Kathuria, 1977).  The level of HPRT activity is related to the 
number of X-chromosomes present in mouse embryos prior to X-chromosome 
inactivation (Monk and Harper, 1978).  The level of HPRT activity in bovine 
embryos has also been related to the number of X-chromosomes (Gutierrez-Adan  
et al., 2000). 
 Downs (1997a) studied the effect of hypoxanthine on oocyte maturation of 
mouse embryos.  The results of this study determined that hypoxanthine is 
responsible for arresting maturation of mouse embryos.  The arrest of mouse oocyte 
maturation by hypoxanthine can be overcome by the addition of cyclic-AMP 
(Downs, 1997b). 
 Recently, Bredbacka (2001) hypothesized that HPRT is responsible for the 
faster development of male mouse and cow embryos.  This effect of HPRT is 
attributed the detoxification of reactive oxygen species.  This hypothesis is 
supported with studies of bovine embryos by Gutierrez-Adan (2000). 
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 The present study utilizes constructed mouse lines overexpressing HPRT to 
determine if HPRT has an effect on the cell number of mouse blastocysts.  In 
addition, to the cell number of blastocysts the embryo growth rates and embryo sex 
ratios of the transgenic mouse lines will be evaluated.    
Materials and Methods 
Transgenic Mice 
The lines HPRT-A and HPRT-B [TgN(HPRT)ARlm and TgN(HPRT) 
BRlm, respectively] were derived by pronuclear microinjection of the HPRT 
transgene at the Louisiana State University Pennington Biomedical Research 
Center. 
The HPRT transgene was constructed by excising the agouti fragment of the 
PGK-agouti plasmid (Klebig et al.,1995) by using PstI digestion.  The full length 
mouse HPRT cDNA (Konecki et al., 1992) was ligated to the PGK plasmid and the 
expression cassette removed by digestion with EcoRI-ApaI. 
The HPRT transgene was suspended at a concentration of 3 ng/ml in Tris-
EDTA (pH 8.0) buffer.  The HPRT transgene was injected into either the male or 
female pronuclei of FVB/N mouse sperm-exposed ovum held in place by a ~50 µ 
diameter holding pipette.  An injection pipette (diameter of < 1 µ) was passed 
through the zona pellucida, the vitelline membrane of the ovum and the pronuclear 
membrane.  The HPRT transgene (~3 pg) was then deposited in the pronucleus by 
applying positive pressure until the pronucleus had enlarged by at least twice the 
original size.  The injection pipette was then removed from the ovum.  All ova were 
collected and incubated as described herein.        
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Transgene Expression  
To confirm that the HPRT transgene was being transcribed in the mouse 
embryos being studied, rt-PCR was performed on groups of ten 4-cell mouse 
embryos using the procedures described by Collins et al. (1995), with primers 
specific for the HPRT transgene. 
Embryo Collection and Culture Conditions  
 Male mice hemizygous for the HPRT transgene were placed with female 
mice immediately after administration of 5 IU of human chorionic gonadotropin 
(Sigma, St. Louis MO).  The female mice were administered 5 IU of equine 
chorionic gonadotrpin (Sigma, St. Louis, MO) 48 hours prior to the 5 IU of human 
chorionic gonadotropin.  The male mice were derived from either the HPRT-A or 
HPRT-B transgenic lines.  Coitus was estimated to have occurred at 12:00 am.  
Embryos were collected from the oviducts the following morning from females 
exhibiting vaginal mucus plugs.  Embryos obtained form the same lines were 
pooled per replicate.  This experiment had 5 replicates. 
 The embryos were collected by excising the oviducts from the female mice 
that were sacrificed by cervical dislocation.  The oviducts were placed into M16 
medium (Sigma, St. Louis, MO) and the embryos removed from the oviducts by 
excising the cumulus masses with watchmaker forceps and a 26-gauge needle.  The 
embryos were cultured in 100 µl of M16 medium for 24 hours.  The embryos at this 
point were transferred to 100 µl of M16 medium supplemented with 4 mg/ml of 
bovine serum albumin (BSA Fraction-V, Sigma, St. Louis, MO).  An embryo 
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exhibiting signs of compaction 48 hours after embryo collection was transferred 
individually into 35 µl of M16 medium with 4 mg/ml BSA.  The medium was 
changed 48 hours later.  All culture was carried out in 5 % CO2 air and 37oC.   
Embryo Scoring  
Beginning 72 hours post-coitum (pc) embryos were assigned a Collins-
Ryan Embryo Development (C-RED) score.  The C-RED was adapted from the 
RED score developed by Ryan et al. (1992).  The C-RED score consists of 20 
scores ranging from 0.01 to 5.00 at intervals of 0.33.  A score of 0.01 is a 
degenerate embryo.   
The scores from 0.33 to 1.00 are based on the degree of compaction of 
morula.  A score of 1.00 is an embryo exhibiting complete compaction.  The scores 
from 1.33 to 2.00 indicated the degree of blastocoel formation.  A score of 2.00 is 
assigned to an embryo with 50% of the volume of the embryo comprised of the 
blastocoel.  The scores from 2.33 to 3.00 are assigned to embryos based on a 
blastocoel size greater than 50% the volume of the embryo without zona pellucida 
thining.  A score of 3.00 indicates a blastocoel that comprises the vast majority of 
the embryo without zona pellucida thinning.  The scores from 3.33 to 4.00 are 
assigned based on evidence of zona pellucida thinning without hatching.  A score 
of 4.00 is assigned to an embryo with the greatest amount of zona pellucida 
thinning prior to hatching.  The scores from 4.33 to 5.00 are assigned based on the 
degree of embryo hatching.  A 4.33 score is assigned to an embryo less than 50% 
outside the zona pellucida.  A 4.66 score is assigned to an embryo more than 50% 
outside the zona pellucida.  A 5.00 score is assigned to an embryo completely zona 
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pellucida free.  The C-RED scores were assigned at 8-hour intervals until 128 hours 
post-coitum.      
Blastocyst Cell Number Determination  
At 128 hours pc any embryo that had cavitated was stained with Hoechst 
33345 (1 mg/ml for 5 minutes) and mounted on glass slides by air drying using the 
method to flatten the embryo (Dyban, 1982).  The embryos were then 
photographed with a Cannon SLR 35 mm AE1 camera using 400 ASA 
KodaChrome color slide film.  The camera was attached to a Nikon TE 200 
inverted microscope with a 40X objective.  The embryos were illuminated with 
ultraviolet light for photography. 
Following development of the film the images of the embryo were projected 
onto a dry erase board using a Kodak color slide projector situated 4.6 m from the 
board.  All visible cells were marked on the board and counted. 
Embryo Sex and Genotype Determination  
Following photomicroscopy individual embryos were recovered from the 
slides by rehydrating with 8 µl of phosphate-buffered saline containing 4 mg/ml of 
polyvinylpyrrolidone (PBS-PVP, Sigma, St. Louis, MO).  They were then 
individually transferred to 0.5-ml Eppendorf microcentrifuge tubes and frozen at    
–70oC until assayed.   
A 10-µl volume of lysis buffer (50 mM KCl, 10 mM Tris-Cl, pH 8.3, 0.45% 
Nonidet P-40 and 0.45% Tween 20) with 100 µg of proteinase K was added to the 
8 µl of the embryo lysate.  The embryo lysated sample was then incubated at 55oC 
for 1 hour followed by 99oC for 10 minutes. 
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PCR to determine the sex of the embryo was performed on 9 µl of the 
embryo sample using 1,000 nM of each oligonucleotide primer described by 
Aansen and Medrano (1990) and designed to amplify a 450 base pair region of the 
mouse ZFX/ZFY gene.  The thermocycle profile consisted of 5 minutes at 95oC 
followed by 50 cycles of 1 minute at 95oC, 1 minute at 55oC, and 1 minute at 72oC 
and a final 10 minutes at 72oC.  The PCR was performed using a 1X PCR buffer, 
200 µg of dNTP’s (Gibco, Bethesda, MD), 2.5 units of Taq Polymerase (Gibco, 
Bethesda, MD) and 150 mM of MgCl.  Approximately 0.1 µl of this reaction was 
used as the PCR template in a subsequent reaction.  This reaction used primers 
mgc02-28-1b and 2b.  Using the same reaction conditions, as the previous reaction, 
this reaction was thermocycled for 35 cycles.  A 15-µl volume of the resulting 
reaction was digested to completion with HaeII restriction endonuclease in a 20-µl 
total volume at 37oC.  A MJ Research PTC-150 minicycler was used for all PCR 
reactions. 
The remaining 9 µl of embryo sample was amplified with primers, mgc02-
10-3b and mgc02-10-4b, specific for the HPRT transgene using the reaction 
conditions herein.  A 3% agarose gel (SeaKem, FMC, Portland, ME) was used to 
resolve the PCR sex determination and embryo genotyping products.  The 
fragments were visualized following ethidium bromide staining using ultraviolet 
illumination. 
The PCR assays were validated prior to embryo sex and genotype 
determination with 12.5 pg/µl of genomic DNA treated the same as the 8 µl of 
embryo lysate.  Positive controls of genomic DNA were run with each assay.  
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Negative controls of the embryo lysis buffer without embryo or genomic DNA 
samples were run with each assay.  PCR failure was most often attributed to sample 
loss or damage from the recovery technique. 
Statistical Analysis  
The deviation of sex and genotype from the expected was tested for 
statistical significance by Chi-square analysis (Bredbacka and Bredbacka, 1996).  
An analysis of variance for repeated measures was used to examine the effects of 
time and sex and genotype of the embryos on the C-RED score.  The relationship 
of sex and genotype and the embryo cell number was analyzed using a linear 
regression model (Stokes et al., 1995).  All statistical procedures were performed 
using version 8.0 of the SAS (Cary, NC) software for windows. 
Results 
 The objective of this study was to study the effect of increased expression 
of HPRT in mouse embryos on the resulting cell number in each blastocyst.  To 
accomplish this, two mouse lines shown to overexpress HPRT were used in this 
study. 
 To confirm that the HPRT transgene was being transcribed in mouse 
embryos obtained from nontransgenic (+/+) females mated to males hemizygous 
(Tg/+) for the HPRT transgene, rt-PCR was performed on groups of 4-cell mouse 
embryos using primers specific for the HPRT transgene (Figure 18). 
 Donor females (n=13) produced a total of 312 embryos over 5 replicates.  
There was no detectable difference between embryos obtained from lines HPRT-A 
and HPRT-B.  Of the 166 embryos surviving culture to the blastocyst stage, 105 
were from females mated to line HPRT-A males and 61 were from females mated 
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Figure 18.  rt-PCR products from groups of ten 4-cell embryos derived from two 
lines (HPRT-A, lane 6 and HPRT-B, lane 4) and liver total RNA from a mouse of 
known genotype (lane 2).  Lane 7 is the 100 bp ladder.  Lanes 1, 3, 5 are rt-PCR 
products from liver total RNA, HPRT-B embryos and HPRT-A embryos, 
respectively, without reverse transcriptase.  Numbers on the right refer to base 
pairs. 
 
 75
to HPRT-B males.  There were 136 blastocysts were recovered from the slides for 
sex and genotype determination, and the sex and genotype was determined for 70 
of the blastocysts (Figure 19).   
 Of the 70 embryos, 5 (7%) were female and transgenic, 16 (22.5%) were 
female nontransgenic, 18 (25.7%) were male transgenic and the remaining 31 
(44.3%) were male and nontransgenic.  These values were not significantly 
different from the expected ratios (χ2 test). 
 There was not a significant difference between the mean number of cells in 
male and female blastocysts (72.8 and 75.1, respectively).  The embryos with 
positive PCR results for the HPRT transgene had 80.9±4.6 cells/blastocyst 
compared with 69.9±3.6 cells/blastocyst for the embryos lacking the HPRT 
transgene (Figure 20).  
 The C-RED scores are shown in Figure 21.  There was not a significant 
difference in the C-RED score profiles of the embryo groups.  However, those 
embryos that were female and transgenic tended to plateau between 80 and 88 
hours pc.  This was followed by a slight decrease in developmental rate at 112 
hours pc with a compensatory increase from 112 to 120 hours pc. This can be 
compared with the female nontransgenic embryos and the male transgenic and 
nontransgenic embryos, where a steady increase in development from 80 to 120 
hours was noted.   
Disscussion 
 The HPRT gene is a highly conserved mammalian X-linked gene.  In all 
mammals studied the HPRT gene has greater than 95% homology (Jiralerspong and 
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Figure 20.  The mean cell number/embryo (±SE) of FVB/N mouse blastocysts 
overexpressing the HPRT transgene.
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Figure 21.  The mean Collins-Ryan Embryo Development (C-RED) scores for 
mouse blastocysts overexpressing HPRT.  Female transgenic (F/Tg), female 
nontransgenic (F/+),  male transgenic (M/Tg) and male nontransgenic (M/+). 
 
Hours Post-Coitum
72 80 88 96 104 112 120 128
C
-R
ED
 S
co
re
s
0
1
2
3
4
5
F/Tg 
F/+ 
M/Tg 
M/+ 
 79
Patel, 1996).  The mouse HPRT gene is a 33 kilobase gene that is located on the 
long arm (Xq26-q27) of the mouse X-chromosome (Shows and Brown, 1975).  The 
mouse HPRT gene has 9 exons (Shows and Brown, 1975). 
 The mouse HPRT mRNA is 1,292 base pairs long.  There is a 657 base pair 
open reading frame preceded by a 87 base pair 5’ noncoding sequence, and 
followed by a 548 base pair 3’ noncoding sequence (Konecki et al., 1982).  The 3’ 
noncoding sequence contains three polyadenylation signals.  Two of the 
polyadenylation signals are overlapping. 
 As expected there was HPRT transgene derived mRNA in 4-cell embryos 
from nontransgenic females mated to transgenic males.  This coupled with HPRT 
activity in preimplanation mouse embryos of the two mouse lines (HPRT-A and 
HPRT-B) overexpressing HPRT, confirm that the embryos used in this study have 
increase HPRT mRNA levels and HPRT activity after embryonic genomic 
activation. 
 Of concern is the failure to recover substantial PCR sex and genotype 
information on the embryos used in this study.  While 81.9% of the embryos were 
recoverable from the slides, only 42.2% of the blastocysts could be reliably sexed 
and genotyped.  This failure is likely due to irreversible damage incurred during the 
staining and photographing process.  At present, an alternative to determining the 
number of cells in the blastocysts was not available. 
The low number of embryos producing PCR results may be a necessary 
burden for obtaining the cell number of the blastocysts analyzed in this study and 
categorizing them based on sex and genotype.  While it was surprising to detect a 
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significant effect of genotype on embryo cell number, it was more unexpected to 
see a lack of effect of sex on cell number, since the previous studies with the same 
transgenic lines found a difference in blastocyst size. 
Peippo and Bredbacka (1995) detected a larger number of blastomere in 
male mouse embryos.  The HPRT gene was implicated in that study as the cause of 
the greater number of cells in the male embryos.  Similarly, Bredbacka and 
Bredbacka (1996) found an increase in the number of cells in male bovine embryos 
but indicated that this was due to the HPRT gene.  Tusonda et al. (1995) detected a 
greater rate of blastomere cleavage for male mouse embryos compared with female 
mouse embryos.  Similar results for mouse embryos were reported by Peippo and 
Bredbacka (1995).  The male mouse embryos had a greater rate of blastomere 
formation than female mouse embryos in the latter study.  In addition, Valdivia et 
al. (1993) showed that male mouse embryos formed a blastocoel earlier than female 
embryos.  These studies attributed this difference to the activity of two X-
chromosomes in the female embryos after genomic activation prior to X-
chromosome inactivation. 
 Bredbacka and Bredbacka (1996) also attributed the faster development of 
male bovine embryos to the presence of two X-chromosomes in female embryos.  
However, Avery et al. (1989) attributed the faster development of male in vivo-
produced bovine embryos to the blastocyst stage to the presence of the Y-
chromosome in the male embryos.  This was followed by a report of faster 
development of male bovine IVF-derived embryos to the blastocyst stage (Avery et 
al., 1991), and this was also attributed to the activity of the Y-chromosome.  Xu et 
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al. (1992) showed a difference in the rate of growth of bovine embryos.  This study 
reported faster development of male embryos to the blastocyst stage.  Cassar et al. 
(1994) detected a faster rate of development for male pig embryos.  This was 
detected both before and after hatching.  These studies agree with the sex ratio 
(67% male: 33% female) found in this experiment with transgenic mouse embryos. 
 The results of this study indicate that overexpression of HPRT in 
preimplantation mouse embryos alters the cell number of blastocysts, but does not 
significantly alter the sex ratios or C-RED score profiles.  This could be the effect 
of too few embryos yielding PCR data in the present study. 
This leads to the conclusion that HPRT is effecting preimplantation embryo 
development of mouse embryos.  Peippo and Bredbacka (1995) implied HPRT may 
be one of the agents responsible for the deviant development of female compared 
with male preimplantation embryos.  It would be interesting to determine if the 
same gene is also affecting the altered sex ratios of an economically valuable 
species with a different placental type, such as the cow.  Bredbacka and Bredbacka 
(1996) indicated that HPRT was the gene that ultimately caused the faster 
development of the male bovine embryos.  In addition elucidation of the 
mechanism of altered development rates may allow for greater control of in vitro 
embryo development. 
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THE EFFECT OF THE HYPOXANTHINE PHOSPHORIBOSYL 
TRANSFERASE GENE IN CO-CULTURE OF MOUSE AND BOVINE 
EMBRYOS 
 
Introduction 
 Bredbacka and Bredbacka (1996) reported that male bovine embryos 
developed faster to the blastocyst stage than female bovine embryos.  This was 
attributed to the activity of two hypoxanthine phosphoribosyl transferase (HPRT) 
genes in female embryos (Bredbacka, 2001).  Peippo and Bredbacka (1995) 
detected a faster rate of blastomere cleavage for male mouse embryos compared 
with female mouse embryos.  The activity of two X-chromosomes in the female 
embryo was implicated in the retarded development of the female mouse embryos. 
Avery et al. (1989) have previously reported faster development of male 
bovine embryos to the blastocyst stage than female bovine embryos.  This was also 
noted with bovine IVF-derived embryos (Avery et al., 1991).  In these studies, the 
presence of the Y-chromosome in male embryos is assumed to be responsible for 
the faster development of the male embryos.  Similarly, Avery et al. (1992) 
considered the presence of the Y-chromosome in male bovine embryos to increase 
their rate of growth compared with female bovine embryos.  The male embryos in 
this study formed a blastocoel faster than the female embryos. 
The difference in growth of male and female embryos has been expressed in 
various ways.  Callesen et al. (1995) compared the percentage of male to female 
bovine embryos at the blastocyst stage.  In this study, there was a greater number of 
male blastocyst than female blastocyst.  Carvalho et al. (1996) and Hochman et al. 
(1996) detected a difference in the time of blastocoel formation among male and 
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female bovine embryos.  The male embryos in these studies formed a blastocoel 
earlier than the female embryos.  Valdivia et al. (1993) considered the greater 
increase in the number of blastomeres of male mouse embryos as an indication of 
faster male development.  Similarly, Peippo and Bredbacka (1995) detected a faster 
rate of cleavage for male mouse embryos compared with female mouse embryos. 
HPRT is an X-linked gene responsible for the salvage of purines (Konecki 
et al., 1982).  HPRT catalyzes the conversion of hypoxanthine and guanine to 
inosine monophosphate (Konecki et al., 1982).  In mouse and bovine embryos prior 
to X-chromosome inactivation, the level of HPRT activity is related to the number 
of X-chromosomes present in the embryos (Monk and Harper, 1978; Gutierrez-
Adan et al., 2000). 
Downs (1997a) studied the effect of hypoxanthine on mouse oocyte 
maturation.  This study and Downs (1997b) determined that hypoxanthine is 
responsible for arresting maturation of mouse oocytes, and this effect of 
hypoxanthine could be reversed by cyclic-AMP (Downs, 1997b). 
Gutierrez-Adan (2000) hypothesized that HPRT is responsible for the faster 
development of male bovine embryos.  This was attributed to the detoxification of 
reactive oxygen species by HPRT.  This hypothesis was recently supported for 
bovine embryos by Bredbacka (2001). 
This study is designed to determine if the extra-embryonic level of HPRT 
activity can effect the number of blastomere in mouse and cow embryos.  This 
study uses a cell line with the HPRT gene (Sanford et al., 1948) and a cell line 
without the HPRT gene (Littlfield, 1963).  
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Material and Methods 
Mouse Embryos 
 Frozen B6D2F1 mouse embryos were obtained from Charles River 
Laboratories and thawed according to the their instructions.  Briefly, the straws 
containing the sperm-exposed ovum were removed from the liquid nitrogen and 
allowed to thaw at room temperature for 2 minutes.  The contents of the straw were 
mixed by shaking vigorously and then the straw was placed for 3 minutes in a 37oC 
water bath with the sealed end of the straw exposed to the air.  After 3 minutes the 
straw was then incubated for 2 minutes in a room temperature water bath with the 
plugged end of the straw exposed to the air.  The contents were then expelled into a 
35 mm Petri dish and allowed to stand at room temperature for an additional 2 
minutes.   
The embryos were then recovered and placed into a 50 µl of M16 medium 
(Sigma, St. Louis, MO) under oil and incubated at 37oC with 5 % CO2 air for 48 
hours.  According to the commercial supplier the sperm-exposed ovum were frozen 
at 10 hours post-copulation (copulation was considered to occur at 12:00 am 
following injection of human chorionic gonadotrophin).  The data reported herein 
are based on the time of embryo thawing at this station. 
Bovine Embryos 
 Bovine embryos were obtained from the basic in vitro maturation, in vitro 
fertilization and in vitro culture procedure used in this laboratory (Zhang et al., 
1992).  Mature bovine oocytes were used after collection from an abattoir by a 
commercial supplier (Ovagenix, San Angelo, TX) and shipment overnight (22 
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hours after oocyte collection) to the Louisiana State University, Embryo 
Biotechnology Laboratory in St. Gabriel, Louisiana. 
 The bovine oocytes were matured at 37oC in M199 supplemented with 5% 
fetal bovine serum (Sigma, St. Louis, MO).  At 21 hours following oocyte 
collection a 0.5-ml straw of bovine sperm (Holstein, #7H3694) was thawed by 
placing it in a 37oC water bath for 1 minute, and the semen expelled into a sterile 
15-ml centrifuge tube.  To the 0.5 ml of semen 5.5 ml of Brackett-Oliphant medium 
(Brackett and Oliphant, 1975) supplemented with 1 mg/ml of caffiene-sodium 
benzonate (Sigma, St. Louis, MO) and 3.6 IU/ml of heperin sulfate (Sigma, St. 
Louis, MO) was added.  The sperm suspension was then centrifuged at 1,200 r.p.m. 
with an H-10008 rotor and a Sorvall RT6000 centrifuge for 6 minutes.  The 
supernant was removed and the pellet was resuspended with 6 ml of the 
supplemented Brackett-Oliphant medium, and again centrifuged for 6 minutes.   
Following this second centrifugation, the supernant was removed and the 
pellet was resuspended with 4 ml of the supplemented Bracket-Oliphant medium 
and an additional 4 ml of Brackett-Oliphant medium supplemented with 6% fatty 
acid-free bovine serum albumin (FAF-BSA, Sigma, St. Louis, MO) was added.  
Then 500 µl (687,000 sperm) of this 8 ml sperm suspension was placed into each 
well of a 4-well culture dish (1.5 cm diameter/well) and the dish was subsequently 
placed at 39oC in 5 % CO2 air while the oocytes were washed. 
 The oocytes (200/replicate) with attached cumulus cells were washed by 
removing the oocytes from the maturation medium and moving all 200 oocytes 
through three 35 mm Petri dishes containing 2 ml of Bracket-Oliphant medium  
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supplemented with 3% fatty acid-free bovine serum albumin.  From the last dish, 
50 oocytes were transferred with 50 µl of medium to one of the 500-µl sperm 
suspension wells.  The oocytes and sperm were then incubated at 39oC in 5% CO2 
air for 5 hours. 
 After the 5 hours of incubation with the sperm, the oocytes were washed (as 
a group 200/replicate) by sequential moving them through the 8 wells of two 4-well 
dishes containing 400 µl of CR1aa medium (Rosenkrans and First, 1994) 
supplemented with 5% fetal bovine serum and 10 µg/ml of insulin (human 
recombinant, Sigma, St. Louis, MO).  From the last well, 50 of the oocytes were 
transferred with 50 µl of medium to a well of a 4-well dish containing 500 µl of the 
supplemented CR1aa medium.  When they were placed into the treatment groups 
the resulting embryos were then incubated at 39oC in 5% CO2 air for 60 hours. 
Cell Lines 
 Bovine cumulus cells were obtained by culturing 50 bovine embryos with 
attached cumulus cells in a well of a 4-well dish with 500 µl of CR1aa medium, 
supplemented as above for 5 days (the medium was changed once after 3 days) and 
then removing the embryos from the resulting monolayer and detaching the cells by 
exposure to 0.01% Trypsin-EDTA (Gibco, Bethesda, MD) for 5 minutes at room 
temperature.  The resulting cell suspension was placed into sequentially larger 
culture vessels until the culture was maintained in a 25-mm culture flask 
supplemented with CR1aa medium and subpassed every 3 days.  Two separate 
cultures derived in this fashion were used in this experiment and all the cells used 
in this study were between fifth and tenth subpassages. 
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 Two cell lines, one with hypoxanthine phosphoribosyl transferase activity 
(CCL-1.0) and one without hypoxanthine phosphoribosyl transferase activity 
(CCL-1.4), were acquired from American Type Culture Collection (ATCC, 
Rockville, MD), and are referred to here as HPRT-positive and HPRT-negative, 
respectively. 
 The HPRT-positive cell line is a continous cell line that Sanford et al. 
(1948) derived from a 100-day-old C3H/An mouse.  The cells are derived from 
adipose and areolar tissue.  The HPRT-negative cell line was isolated from the 
HPRT-positive cell line described by Littlefield (1963).  The HPRT-negative cell 
line is deficient in the HPRT gene.  This deficiency makes the HPRT-negative cells 
sensitive to HAT (hypoxanthine, aminopterin and thymidine) selection.  The 
sensitivity of the HPRT-negative and the insensitivity of the HPRT-positive cell 
lines to HAT selection was determined prior to this experiment.  This was 
performed by culturing for 3 days in the presence of HAT selection (data not 
shown). 
 The HPRT-positive and HPRT-negative cell lines were maintained in 75 
cm2 tissue culture flasks (Falcon, Sigma, St. Louis, MO).  The cells were 
maintained with Dublecco’s Modified Eagle’s Medium (DMEM, Gibco, Bethesda, 
MD) supplemented with 5% fetal bovine serum at 37oC in an atmosphere of 5% 
CO2.  The cultures were subpassaged at 3-day intervals.   
Experimental Design 
 Starting 24 hours before the start of the experiment, one well of a 4-well 
dish was seeded with 10,000 cells from one of the three cell lines mentioned 
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previously.  The cells were then incubated in 500 µl of the supplemented CR1aa 
medium overnight. 
 For the mouse embryos, any embryo that exhibited evidence of compaction 
48 hours after thawing was placed into co-culture, with one of the three cell lines, 
in CR1aa medium until 118 hours after thawing.  At this time, a Collins-Ryan 
Embryo Development (C-RED) score was assigned at 8-hour intervals for each 
embryo beginning 56 hours post-thaw.  The mean score for each treatment well 
was determined by averaging the scores of all the embryos in each well at each 
time point.  The medium was changed twice during culture. 
At 118 hours post-thaw, any embryo that had cavitated was stained with 
Hoechst 33345 (1 mg/ml for 5 minutes). The embryos were mounted on glass 
slides using the method to flatten the embryo (Dyban, 1982).  Embryo photographs 
were made with a Nikon inverted Diaphot microscope with 40X objectives and a 
Cannon SLR 35mm AE1 camera. The film used was 400 ASA KodaChrome color 
slide film.  The embryos were photographed with ultraviolet illumination.  The 
images of the embryos were projected onto a dry erase board and all visible cells 
were marked on the board and counted.  The images were projected with a Kodak 
color slide projector situated 4.6 m from the board.  This experiment contains 5 
replicates with 20 embryos/treatment. 
 After the bovine embryos were incubated for 60 hours post-insemination, 
the cumulus cells were stripped off the embryos by vigorously pipetting them with 
a pulled Pasteur pipette of ~180 µ in diameter until all the cumulus cells were 
detached.  Any embryo that had 4 or more cells was then randomly placed into 1 of 
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3 wells of a 4-well culture dish containing 1 of the cell lines mentioned earlier for 
co-culture.  The embryos were cultured until 192 hours post-insemination at which 
time any embryo that had cavitated was stained with Hoechst 33345 (1 mg/ml for 5 
minutes).  Using the air drying method reported by Dyban (1982), the embryos 
were mounted on glass slides and flattened.  The embryos were then photographed 
using a Nikon inverted Diaphot microscope with 10X objectives.  The embryos 
were illuminated with ultraviolet light. Photographs were made with a Cannon SLR 
35mm AE1 camera using 400 ASA KodaChrome color slide film.  Using a Kodak 
color slide projector the images, after development of the film, were projected onto 
a dry erase board 4.6 m from the projector.  All visible cells were marked and 
counted.  This experiment had 5 replicates. 
Results 
Mouse Embryos 
 There was not a significant difference in the number of mouse blastocyst 
and hatched blastocysts between treatment groups (Table 4; P>0.05).  Of the one 
hundred 8-cell embryos co-cultured with the HPRT-positive cell line, 82 developed 
blastocoels and 6 embryos hatched.  Similarly, of the one hundred 8-cell embryos 
co-cultured with the HPRT-negative cell line 75 embryos developed blastocoels 
and 6 hatched.  This can be compared with the one hundred 8-cell embryos co-
cultured with the bovine cumulus cells.  Of these, 76 developed blastocoels and 8 
embryos hatched. 
  There was, however, a significant difference in the number of blastomeres 
contained in each blastocyst (Figure 22).  There were significantly more 
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blastomeres (±SE) (78.5±8.86) in the blastocysts that were co-cultured with the 
cells containing the hypoxanthine phosphoribosyl transferase gene than in the 
blastocysts co-cultured with bovine cumulus cells (59.5±5.78) and those co-
cultured with cells missing the hypoxanthine phosphoribosyl transferase gene 
(64.0±3.1) (P<0.05). 
There was not a significant difference between the developmental rates of 
the embyos co-cultured with the HPRT-positive, HPRT-negative and bovine 
cumulus cells, as indicated by the C-RED scores (Figure 23).  
Bovine Embryos 
 There was a detectable difference in the rate of development to blastocyst 
from the 8-cell stage (Table 5).  There were significantly (P<0.05) fewer 
blastocysts (31.2%) in the group of embryos cultured with bovine cumulus cells 
than the group cultured with the cells missing the hypoxanthine phosphoribosyl 
transferase gene (43.2%).  There was no detectable difference between the number 
of blastocysts obtained from co-culturing the embryos with the HPRT-positive cells 
and those co-cultured with HPRT-negative cells (41.8% and 43.2%, respectively).  
In addition, there was no significant difference in the number of blastocyst hatching 
between the treatment groups.  The embryos co-cultured with the HPRT-positive 
cells, HPRT-negative cells and bovine cumulus cells with 8.1, 8.8 and 7.0% of the 
embryos hatching, respectively. 
 Also, there was not a significant difference in the number of blastomeres 
regardless of the culture treatment groups.  There were 191±10.1 cells/blastocyst 
co-cultured with the cells containing the hypoxanthine phosphoribosyl transferase 
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Figure 22.  The mean embryo cell number (±SE) for mouse blastocysts co-cultured 
with HPRT-positive, HPRT-negative and bovine cumulus cells.  a,bBars with 
different superscripts are significantly different (P<0.05).
Treatment
HPRT Positive HPRT Negative Cumulus
C
el
l N
um
be
r/E
m
b
ry
o
0
20
40
60
80
100
 
a
b
 93
 
 
 
 
Figure 23.  The mean Collins-Ryan Embryo Development (C-RED) scores of 
mouse blastocysts co-cultured with HPRT-positive, HPRT-negative and bovine 
cumulus cells.
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gene compared with 200±7.3 cells/blastocyst co-cultured with the cells missing the 
hypoxanthine phosphoribosyl transferase gene and 195±6.8 cells/blastocyst co-
cultured with the bovine cumulus cells (Figure 24).    
Discussion 
In the present study the larger number of blastomeres in the mouse embryos 
co-cultured with the HPRT-positive cells is supported Peippo and Bredbacka 
(1995), who showed that male mouse embryos have a faster rate of blastomere 
cleavage than do female mouse embryos.  The latter report suggested that the 
HPRT gene was the factor causing the accelerated male embryo growth.  The same 
effect of sex on the rate of blastomere cleavage with mouse embryos has been 
reported by Tusonda et al. (1995).  They noted that male mouse embryos had an 
increased number of blastomeres compared with female embryos.  Similarly, 
Valdivia et al. (1993) detected an increase rate of blastocoel formation with mouse 
embryos.  The male embryos in this study formed blastocoels earlier than the 
female embryos.   
Cassar et al. (1994) reported an alteration in the rate of growth, before and 
after hatching, between male and female pig embryos.  Xu et al. (1992) showed that 
male bovine embryos developed faster than female bovine embryos.  This study 
based development on the time of in vitro blastocoel formation.  Avery et al. (1989) 
used bovine in vivo-derived embryos determined that there was a significant effect 
of sex on embryo development.  The male embryos in the latter study reached the 
blastocyst stage at a faster rate than the female embryos.  The same group working 
with bovine IVF-derived embryos detected a faster development to the blastocyst 
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Figure 24. The mean cell number (±SE) of bovine blastocysts co-cultured with 
HPRT-positive, HPRT-negative and bovine cumulus cells.
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stage by the male embryos (Avery et al., 1991).  Among the bovine embryos 
produced in a subsquent study (Avery et al., 1992), a greater number of males 
developed blastocoel cavities. 
The presence of the Y-chromosome in the male embryos has been proposed 
in several studies to be the cause of the accelerated male embryo development 
(Avery et al., 1989; Avery et al., 1991; Avery et al., 1992).  Other groups have 
proposed the presence of two X-chromosomes in the female embryos as the cause 
of the hindered female embryo growth (Valdivia et al., 1993; Peippo and 
Bredbacka, 1995; Bredbacka and Bredbacka, 1996; Bredbacka, 2001).   
Peippo and Bredbacka (1996) indicated the HPRT gene was responsible for 
the faster growth of male bovine embryos.  Similarly, the HPRT gene has been 
implicated in the altered rate of growth of male and female bovine embryos 
(Bredbacka and Bredbacka, 1996).  Gutierrez-Adan et al. (2000) suggested that 
HPRT could be altering the rate of bovine embryo growth through the 
concentration of reactive oxygen species in the embryo.  This HPRT hypothesis 
was further supported by Bredbacka (2001).  This is, however, not supported by the 
results of the present experiment.  An effect of the HPRT cell lines was not 
detected.  The rate of blastocoel formation and blastocyst hatching was not 
significantly different for the embryos co-cultured with the HPRT-positive cells 
compared with the embryos co-cultured with the HPRT-negative cells   However, 
this experiment did not determine the effect of HPRT in the co-culture medium 
alone. 
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 A significantly greater number of bovine embryos co-cultured with the 
HPRT-negative cells developed blastocoels compared with those embryos co-
cultured with bovine cumulus cells.  The blatoceol formation rate of the embryos 
co-cultured with the HPRT-positive cells was not significantly different from the 
embryos co-cultured with the HPRT-neagtive cells or the bovine cumulus cells.  
These results could be a manifestation of the culture conditions required by the 
cumulus cells compared with the specialized treatment cells.  Normal culture of the 
HPRT-positive and HPRT-negative cells requires minimal medium components 
(DMEM) while bovine cumulus cell cultures likely require more medium 
components (CR1aa medium).   
The CR1aa medium, unlike DMEM, contains all essential and nonessential 
amino acids (Rosenkrans and First, 1994).  The greater requirements of the 
cumulus cells could result in a reduced availability of nutrients for the embryos 
when co-cultured with the cumulus cells compared with the less demanding 
established cell lines used in the treatments, thus resulting in a decreased number of 
embryos developing a blastocoel cavity. 
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THE EFFECT OF HYPOXANTHINE PHOSPHORIBOSYL 
TRANSFERASE INHIBITORS ON BOVINE EMBRYO DIAMETER AND 
SEX RATIOS  
 
Introduction 
 Bredbacka and Bredbacka (1996) reported that male bovine embryos 
develop faster to the blastocyst stage than corresponding female embryos.  This 
supported previous work by the same group with mouse embryos (Peippo and 
Bredbacka, 1995).  In this study, the male mouse embryos had a greater increase in 
blastomere number than the female precompaction embryos.  The presence of two 
X-linked hypoxanthine phosphoribosyl transferase (HPRT) genes in the female 
embryos was implicated as the agent of delayed female embryo growth in both of 
these studies.  This involvement of HPRT in the faster development of male 
embryos has recently been supported using bovine embryos by Guiterrez-Adan et 
al. (2000).  
 Similar disparity of growth between male and female embryos was 
previously reported by Avery et al. (1989).  In this study, male bovine embryos 
reached the blastocyst stage faster than female embryos.  However, unlike the 
findings of Bredbacka and Bredbacka (1996), the presence of the Y-chromosome in 
the male embryos was considered the factor effecting the growth rates of the male 
embryos.  This finding was further supported by Avery et al. (1991) when it was 
determined that male bovine embryos formed a blastocoel faster than female 
embryos.  The Y-chromosome was again implicated by Avery et al. (1992) in a 
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study comparing the growth rates of sexed bovine embryos.  Male embryos in this 
study reached the blastocyst stage prior to female embryos.  
 The difference in growth of male and female embryos has been reported in 
various different ways.  Callesen et al. (1995) chose to compare the percentages of 
bovine embryos developing to the blastocyst stage.  This approach has been 
employed by other groups studying bovine embryos, including Avery et al. (1991, 
1992) and Grisart et al. (1995).  Another method used by Carvalho et al. (1996), 
was to determine the difference in bovine embryo diameter or time of blastocoel 
development.  Hochman et al. (1996) also used the percentage of bovine embryos 
developing to the blastocyst stage as an indication of differential growth.  Other 
studies have reported an increase in the number of blastomeres as an indication of 
greater development of mouse embryos (Valdivia et al., 1993; Peippo and 
Bredbacka, 1995). 
 HPRT an X-linked gene is responsible for the salvage of hypoxanthine and 
guanine (Konecki et al., 1982).  Hypoxanthine and guanine are products of purine 
degradation.  The mouse HPRT gene has more than 95% homology with other 
HPRT genes studied up to this time (Jiralerspong et al., 1996).  The 657 base pair 
open reading frame of the mouse 1,292 base pair HPRT mRNA encodes a 218 
amino acid protein (Konecki et al., 1982; Jiralerspong et al., 1996).   The level of 
HPRT activity has been related to the number of X-chromosomes in mouse (Monk 
and Harper, 1978) and bovine embryos (Gutierrez-Adan et al., 2000) prior to X-
chromosome inactivation. 
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 Hypoxanthine was found to be responsible for the arrest of mouse oocyte 
maturation, reported by Downs (1997a).  Further work by Downs (1997b) 
concluded that the addition of cyclic-AMP would allow the mouse oocytes to 
continue the maturation process.  
Both 6-azauridine and 6-mercaptopurine are purine analogs that decrease 
hypoxanthine phosphoribosyl transferase activity in mammalian gametes and 
embryos (Downs and Dow, 1991).  HPRT activity can be increased by the addition 
of the HPRT substrate hypoxanthine (Jiralerspong et al., 1996).  Intracellular 
hypoxanthine increases glucose transport in mouse embryos (Monk and Kathuria, 
1977).        
Materials and Methods 
Bovine Embryos 
 Bovine IVF-derived embryos were obtained using the basic procedures 
described by Zhang et al. (1992).  Briefly, a straw of frozen sperm (Holstein 
#7H3694) was thawed by placing the 0.5-ml straw in a 37oC water bath for             
1 minute.  The semen was then placed into 5.5 ml of Brackett-Oliphant medium 
(Brackett and Oliphant, 1975) supplemented with 1 mg/ml of caffeine-sodium 
benzonate (Sigma, St. Louis, MO).  In addition the Brackett-Oliphant medium was 
supplemented with 3.6 IU/ml of heparin sulfate (Sigma, St. Louis, MO).  This 
sperm suspension was centrifuged at 1,200 r.p.m. in an H-10008 rotor with a 
Sorvall RT6000 centrifuge for 6 minutes.   
Following removal of the supernant and suspension of the pellet in 6 ml of 
the supplemented Brackett-Oliphant medium the sperm suspension was centrifuged 
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for an additional 6 minutes.  The sperm was then resuspended in 4 ml of the 
supplemented Brackett-Oliphant medium and an additional 4 ml of Brackett-
Oliphant medium supplemented with 6% fatty acid-free bovine serum albumin 
(Sigma, St. Louis, MO).  From this sperm suspension, 500 µl (~687,000 sperm) 
was added to each well of a 4-well culture dish (1.5 cm diameter/well).  The dish 
was placed in a incubator at 39oC and 5% CO2 in air until the addition of the 
oocyctes. 
 Oocytes (200/replicate) were obtained from a commercial supplier 
(Ovagenix, San Angelo, TX) after collection from an abattoir and shipment to the 
Louisiana State University, Embryo Biotechnology Laboratory in St. Gabriel, 
Louisiana.  The oocytes were shipped in maturation medium (M-199 supplemented 
with 5% fetal bovine serum; Sigma, St. Louis, MO) at 37oC.  The oocytes and 
attached cumulus cells were washed by moving all 200 oocytes through three 
consecutive 35 mm culture dishes containing 2 ml of Brackett-Oliphant medium 
supplement with 3% fatty acid-free bovine serum albumin.  From the last of the 
washing dishes, 50 oocytes were placed into each of the 500-µl sperm suspensions 
prepared above.  The oocytes and sperm were then incubated at 39oC and 5% CO2 
in air for 5 hours. 
 Following the 5 hours of incubation as a group, the oocytes were washed 
(200/replicate) with CR1aa medium (Rosenkrans and First, 1994) supplemented 
with 5% fetal bovine serum and 10 µg/ml of insulin (human recombinant; Sigma, 
St. Louis, MO).  This was done by sequentially moving them through the 8 wells of 
two 4-well dishes containing 400 µl of the CR1aa medium (Rosenkrans and First, 
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1994).  To each well of a 4-well dish (containing 500 µl of the supplemented 
CR1aa medium), 25 of the embryos were transferred along with 50 µl of medium.   
The embryos were incubated at 39oC with 5% CO2 in air for 60 hours when 
the embryos were stripped of the cumulus cells. This was performed by vigorously 
pipetting them with a pulled Pasteur pipette of ~180 µ diameter until all the 
cumulus cells were detached.  Any embryo that had 4 or more blastomeres was 
randomly aliquoted into each well of two 4-well dishes, and cultured an additional 
48 hours in the supplemented CR1aa medium. 
 At that time point, 108 hours post-fertilization the medium was changed and 
supplemented with either 1 mM 6-azauridine (Sigma, St. Louis, MO), 1 mM 6-
mercaptopurine (Sigma, St. Louis, MO), 1 mM hypoxanthine (Sigma, St. Louis, 
MO) or water.  Each well in one of the 4-well dishes was then supplemented with 
5.5 mM glucose (Sigma, St. Louis, MO).  The embryos remained in culture until 
192 hours post-fertilization, when the embryos from each treatment group were 
placed individually into 30-µl drops of M2 medium (Sigma, St. Louis, MO) and 
covered with mineral oil. 
Embryo Diameter 
 The embryos were photographed with a Nikon inverted Diaphot microscope 
and 10X objectives using a Cannon SLR 35 mm AE1 camera.  The film was 400 
ASA KodaChrome color slide film.  Following development of the film the images 
were digitized using a Microtek 35t color slide scanner set at 200 dpi resolution.  A 
stage micrometer was used to calibrate the measure tool of Adobe Photoshop 5.0.  
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The measure tool was then used to determine the mean diameter from 3 measured 
axes. 
Embryo Sex Determination  
 Following photomicroscopy individual embryos were washed 3 times 
through PBS containing 4 mg/ml of polyvinylpyrrolidone (PBS-PVP, Sigma, St. 
Louis, MO).  The embryos were transferred to 0.5-ml Eppendorf microcentrifuge 
tubes with 2 µl of PBS-PVP solution and frozen at –70oC until the sex 
determination procedure. 
Prior to the sex determination assay, 10 µl of lysis buffer (50 mM KCl, 10 
mM Tris-Cl (pH 8.3), 0.45% Nonidet P-40, 0.45% Tween 20; Sigma, St. Louis, 
MO) with 10 µg of proteinase K was added to the 2 µl of each embryo sample.  
The samples were then incubated at 55oC for 1 hour followed by 99oC for 10 
minutes. 
The PCR consisted of 1X PCR buffer, 200 µg dNTP’s (Gibco, Bethesda, 
MD), 2.5 units of Taq Polymerase (Gibco, Bethesda, MD), 150 mM MgCl and 
1,000 nM of each oligonucleotide primer (mgc04-64-1b: 5’-
ccaatacacagaggtcatggtggg-3’ and mgc04-64-2b: 5’-ggaagactatgcaggtagcaggtgc-3’) 
designed to amplify a 194 base pair region of the bovine repeat Y-associated gene.  
A minicycler (MJ Research PTC-150) was used for the reaction.  The reactions 
were incubated for 5 minutes at 95oC; followed by 35 cycles of 1 minute at 95oC, 1 
minute at 55oC and 1 minute at 72oC, and a final 10 minutes at 72oC.  The resulting 
reaction products (15 µl) were resolved with a 4% agarose gel (SeaKem, FMC, 
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Portland, ME).  The fragments were visualized by fluorescence following staining 
with ethidium bromide and exposure to ultraviolet light (270 to 280 nm). 
Prior to embryo sex determination, the procedure was validated by diluting 
known genomic DNA to a concentration of 12.5 pg/µl and treating 12 µl of the 
same as the embryo lysate.  Positive controls for each sex were run with each assay 
using the genomic DNA.  To detect contamination negative controls consisted of 
the embryo lysis buffer without embryo or genomic DNA. 
Statistical Analysis 
The deviation of sex from the expected (1:1) was tested for statistical 
significance by Chi-square analysis (Stokes et al., 1995).  An analysis of variance 
for repeated measures was used to examine the effects of treatment on the 
development of the embryos.  The correlation of sex with treatment was tested 
using a regression model.  The relationship of sex and treatment with the embryo 
diameter was analyzed using a general linear model.  All statistical procedures were 
performed using version 8.0 of the SAS software for windows.  This experiment 
contained 6 replicates. 
Results 
 There was a significant difference in the number of blastocysts obtained 
from the embryos cultured with 6-azauridine (19.2% with glucose and 19.2% 
without glucose) and 6-mercaptopurine (20.0% with glucose and 19.2% without 
glucose) from the embryos exposed to hypoxanthine (36.6% with glucose and 
40.0% without glucose) and control (32.5% with glucose and 41.3% without 
glucose) embryos (Table 6). 
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 The embryos cultured in the presence of hypoxanthine and glucose had a 
significant larger diameter (390±24.8 µ) than those exposed to the hypoxanthine 
phosphoribosyl transferase inhibitors (6-Azauridine; 348±19.3 µ without glucose, 
348±30.1 µ with glucose and 6-mercaptopurine; 333±20.7 µ without glucose, 
313±12.9 µ with glucose).  These were also significantly different than the diameter 
of the control embryos (333±30.2 µ without glucose and 324±24.7 µ with glucose) 
(Figure 25). 
 There was not a significant difference between the diameter of male and 
female embryos, with the male embryos having a mean diameter of 347±13.9 µ and 
the female embryos having a mean diameter of 345±12.3 µ (Figure 26).  Similarly, 
there was not a significant effect of sex and exposure to glucose on the mean 
embryo diameter (Figure 27).  The male embryos, with exposure to glucose had a 
mean diameter of 364±23.1 µ and those without exposure to glucose had a mean 
diameter of 333±16.7 µ. This can be compared with the female embryos, with those 
exposed to glucose having a mean diameter of 343±16.5 µ and those without an 
exposure to glucose having a mean diameter of 348±18.8 µ. 
 There was, a significant difference, however, in the mean diameters of the 
male embryos cultured in hypoxanthine (374±23.5 µ) and 6-azauridine (384±36.0 
µ) from the male control embryos (304±24.7 µ) and the female embryos cultured 
with 6-mercaptopurine (317±13.8 µ) (Figure 28)   
 Glucose did not have a significant effect on the sex ratio of the blastocysts 
regardless of the treatment groups.  However, there was a significant difference 
from the expected 1:1 ratio detected in the two hypoxanthine phosphoribosyl 
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Figure 25.  The mean diameter (±SE) of bovine blastocysts cultured in the 
presence or absence of 5.5 mM glucose. 
 
Treatment
      No Added Gluco se            Added Glucose
M
ea
n 
Em
br
yo
 D
ia
m
et
er
 ( µ
)
0
100
200
300
400
500
600
 109
 
 
 
 
Figure  26.  The mean diameter (±SE) of male and female bovine blastocysts. 
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Figure 27.  The mean diameter (±SE) of male and female bovine blastocysts 
co-cultured in the presence and absence of 5.5 mM glucose (Glu). 
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Figure 28.  The effect of sex and treatment on the mean diameter (±SE) of bovine 
blastocysts. 6-azauridine (6-Aza), 6-mercaptopurine (6-Mp), hypoxanthine (Hx) 
and control (Con).  a,b Bars with different superscripts are significantly different 
(P<0.05). 
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transferase inhibitor groups and the control group (Table 7).  The 50% females 
detected in the group of embryos exposed to hypoxanthine was significantly less 
than the 59.2, 75.0 and 64.3% females in the 6-azauridine, 6-mercaptopurine and 
control groups, respectively.  
Discussion 
 Faster development of male bovine embryos to the blastocyst stage has been 
reported by Avery et al. (1989).  Avery et al. (1989) considered the faster rate of 
male embryo development to be the consequence of the Y-chromosome in the male 
embryos.  In further work by Avery et al. (1991) there was a greater number of 
male bovine blastocyst developed in vitro compared with female blastocysts. 
 Valdivia et al. (1993) considered that the presence of two X-chromosomes 
in female mouse embryos was delaying the development to the blastocyst stage 
compared with male mouse embryos.  The same conclusions with mouse embryos 
were reported by Tusonda et al. (1992).  The male mouse embryos in the latter 
study developed faster than the female embryos.  The two X-chromosomes in 
female pig embryos was also considered by Cassar et al. (1994) to be the cause of 
the delayed female embryonic development when compared with the male 
embryos.   In the latter study, an alteration in the rate of growth before and after 
hatching was detected.  These studies are supported by the observations of Xu et al. 
(1992) indicating that slower development of female bovine embryos was 
attributed to the activity of the X-chromosomes. 
 Bredbacka and Bredbacka (1996) considered that the delayed development 
of female bovine embryos was due to the double dose of X-chromosome gene 
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products.  Specifically, Bredbacka and Bredbacka (1996) implicated the HPRT 
gene as the agent of delayed female embryo growth.  This supported the results of 
an earlier study by the same group with mouse embryos (Peippo and Bredbacka, 
1995).  Gutierrez-Adan et al. (2000) also implicated the HPRT gene as the cause of 
the differences in growth of male and female bovine embryos.  However, Peippo et 
al. (2001) concluded that the faster cleavage rate for male bovine embryos was due 
to the presence of glucose.  Furthermore, in the absence of glucose female embryos 
had a faster cleavage rate than the male embryos.  The latter study did not address 
the effect of sex on compaction and blastocoel formation. 
 Both 6-mercaptopurine and 6-azauridine have been used to decrease HPRT 
activity in mouse gametes and embryos (Downs, 1997a).  In addition, hypoxanthine 
has been used to increase HPRT activity in mouse embryos (Downs and Dow, 
1991).  Hypoxanthine, in the concentrations used here, is known to be nontoxic to 
mammalian cells and embryos (Down and Dow, 1991). 
In the current study, glucose with hypoxanthine tended to delay 
development to the blastocyst stage.  This is not surprising since glucose is not 
required for embryo development and may, to some extent, be embryo toxic (Davis 
and Day, 1978; Menezo and Khatchadourian, 1990; Gardner and Lane, 1993).  This 
can be explained by hypoxanthine conversion to inosine monophosphate by HPRT.  
This would expend more phosphoribosyl pyrophosphate and allow the shunting of 
glucose into the pentose phosphate pathway (Fisher and Reicherter, 1984).  This 
would effectively lower the concentration of glucose preventing the detrimental 
effects of its presence in the culture medium. 
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The finding that embryos cultured in the presence of hypoxanthine and 
glucose had larger diameters than the control embryos could also be explained by 
the utilization of glucose to produce phosphoribosyl pyrophosphate.  However, an 
effect of hypoxanthine alone can not be ruled out (Peippo et al. 2001).   
 It was surprising that there was not a difference between the mean diameters 
of the male and female bovine blastocysts in the present study.  It must be kept in 
mind that embryo diameter is only one parameter of embryo development, and 
other studies have reported an increase rate of male bovine embryo development 
without an increase in embryos diameter (Bredbacka and Bredbacka, 1996; Peippo 
et al., 2001). 
 As expected, there was a deviation from the expected 1:1 ratio of male to 
female embryos in the control groups regardless of the glucose concentration in the 
control groups in this study.  Unexpectedly, there were a higher percentage of 
females in these groups.  This is contrary to previous reports with bovine (Avery et 
al., 1991), murine (Peippo and Bredbacka, 1995) and human (Tarin et al., 1995) 
embryos, but is not different to a previous report from this laboratory with bovine 
embryos (Collins, 1997).  This may indicate an effect of the sex determination 
procedure or the in vitro fertilization and culture system used to produce the 
blastocyst.  The sex determination methods used here have been validated with 
genomic controls, both prior to and during the course of these experiments. 
 The concentrations of hypoxanthine used in this study tended to abolish the 
skewed sex ratios.  This result coupled with the nontoxicity of hypoxanthine, will 
have implications, especially in the field of human in vitro fertilization, where it is 
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desirable to culture IVF-derived embryos to the blastocyst stage to avoid multiple 
pregnancies with unaltered live birth sex ratios (Tarin et al., 1995). 
    
 117
CONCLUSIONS 
 The first experiment did not reveal any significant differences in the ability 
of hypoxanthine phosphoribosyl transferase to protect cells from damage by 
reactive oxygen species.  Also, there was no major differences in the growth and 
cell diameter of the two cell lines (HPRT-postive and HPRT-negative).  These 
results, however, are important since the further use of these cells as a model of 
extra-embryonic HPRT activity will not be hampered by any extraneous factor, 
such as cell growth.  
 Mouse embryos transgenic for the HPRT gene were used in the second 
experiment.  A deviation of the sex and genotype ratios from the expected 1:1 
indicated that the HPRT gene is a factor effecting the development of 
preimplantation mouse embryos.  HPRT did not have an effect on the diameter of 
the embryos.  This indicates that the sexual dimorphism of preimplantation mouse 
embryos is due to the action of numerous genes, which may and may not be sex 
related. 
 A relationship was revealed in the third experiment between the number of 
blastomeres in mouse blastocysts and the HPRT transgene.  Mouse embryos 
overexpressing HPRT had a greater number of blastomeres than embryos without 
the HPRT transgene.  The sex of the mouse embryos did not have an effect on the 
number of cells in the blastocysts. 
 In the fourth experiment, HPRT was shown to affect the cell number of 
mouse blastocysts in an extra-embryonic fashion.  The mouse embryos co-cultured 
with the HPRT-postive cells had more blastomeres at the blastocyst stage than 
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those embryos co-cultured with bovine cumulus cells.  The mechanism by which 
this occurs can not be identified at this time.  
This is in contrast with the results obtained in the fifth experiment, where 
there was not a difference in cell number of the bovine embryos co-cultured in the 
presence of cells expressing the HPRT gene and cells lacking HPRT activity.  This 
clearly brings into question the suitability of the use of mouse embryos as a model 
for bovine embryo development. 
 The last experiment compared the sex ratio of bovine blastocysts cultured 
with two HPRT inhibitors and an HPRT inducer.  The embryos cultured with the 
HPRT inducer (hypoxanthine) did not have altered sex ratios as was noted with the 
control embryos and those cultured with the HPRT inhibitors.  The fact that 
hypoxanthine is nontoxic and did not hindered the embryo development, may lead 
to its use in human IVF programs where it is desirable to culture embryos to the 
blastocyst stage without altering the sex ratio.   
 Based on the findings presented herein with the mouse embryos and the 
HPRT gene, the cell model is updated (Figure 29).  This hypothesis states that 
following the massive degradation of mRNA during genomic activation there is an 
altered rate of development of the blastocoel between male and female embryos.   
This results from the increased shunting of phosphoribosyl phyrophosphate into 
GTP.  This decreases the availability of ATP for use by the Na+/K+ ATPase to 
develop the blastocoel in female embryos because of the action of two HPRT 
genes.  This is exacerbated in the presence of increased glucose levels in vitro due 
to the positive feedback of hypoxanthine on glucose transport.  This leads to 
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Figure 29.  Mouse embryo HPRT sexual dimorphism hypothesis. Adenine 
phosphoribosyl transferase (APRT), hypoxanthine phosphoribosyl transferase 
(HPRT), inosine monophosphate (IMP), guanine monophosphate (GMP) adenosine 
diphosphate (ADP) and adenosine triphosphate (ATP).
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increase glucose metabolism to phosphoribosyl pyrophosphate via the pentose 
phosphate shunt. 
It is hoped that the results presented herein will spur further investigations 
to confirm the validity of the hypothesis presented.      
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